The number of people suffering from diabetes is surging, even as tens of millions cannot get the insulin they need, the World Health Organisation said on Friday.
The UN health agency stressed the need to cut prices and dramatically increase access to the life-saving medicine.
More than 420 million people are currently estimated to be living with diabetes globally, marking nearly a quadrupling in the past four decades.
And that number is expected to surge past half a billion by the end of this decade, WHO said Friday.
But despite an ample supply, high prices make it difficult for many diabetics to access the insulin they need to manage their condition.
“There are significant gaps in access to conditioning globally, particularly in lower-income countries,” Kiu Siang Tay, of WHO’s Access to Medicines and Health Products division, told reporters.
In a fresh report, WHO decried a betrayal of the solidarity showed by the Canadian researchers who discovered insulin 100 years ago.
Frederick Banting and John Macleod sold the patent for insulin, which transformed a diagnosis of diabetes from a swift death sentence to a manageable disease, for just one Canadian dollar, insisting the discovery “belongs to the world”.
“Unfortunately, that gesture of solidarity has been overtaken by a multi-billion-dollar business that has created vast access gaps,” WHO chief Tedros Adhanom Ghebreyesus said in a statement.
– ‘Non-competitive’ –
Diabetes is divided into two types.
An estimated nine million people have type 1 diabetes, a chronic condition where the pancreas does not produce enough insulin — the hormone that regulates blood sugar levels.
Most people living with diabetes have type 2, which is associated with obesity and other lifestyle factors and emerges in adults and increasingly among children.
All type 1 diabetics need insulin to survive, and generally, their access is ensured.
Some 63 million people with type 2 meanwhile also need the hormone, according to WHO estimates, but only about half of them can access it.
Diabetes is especially on the rise in lower-income countries, which now account for 80 percent of cases, but the insulin consumption in those countries is lagging due to a range of barriers, it said.
A major problem is that the global insulin market remains dominated by just three companies: Eli Lilly, Novo Nordisk and Sanofi, creating a “non-competitive market environment”.
The report also lamented that the global market had at the start of this century shifted away from human insulin, which can be produced quite cheaply, to much pricier synthetic insulins.
This, it said, had imposed “an untenable financial burden on lower-income countries”.
Tay pointed out that the price for the new insulin analogs could be multiple times higher, but clinical evidence showed that “human insulin usually works equally good … for most people living with diabetes.”
Another problem highlighted in the report was that research and development in the area focus heavily on the needs in high-income countries, even though lower-income nations have the biggest burden.
“WHO is working with countries and manufacturers to close these gaps and expand access to this life-saving medicine for everyone who needs it,” Tedros said.
Earlier this year, the UN agency launched talks with insulin manufacturers and others about ways to meet the growing demand “at prices that countries can afford”.
It said Friday that the industry had made some commitments, including participating in a prequalification programme it introduced in 2019 aimed at bringing more manufacturers into the market.
In commemorating the 2021 World Diabetes Day, the Association of Community Pharmacists of Nigeria (ACPN), has lamented that nearly 100 years after the discovery of insulin and other diabetes medications, they remain largely unavailable and unaffordable for the majority of Nigerians, as 6 million of adult Nigerians are said to be diabetic.
This was contained in a press release, signed and made available to the media by its National Chairman, Pharm. Wale Oladigbolu, in celebration of 2021 World Diabetes Day, themed “Access to Diabetes Care: If not now, when?”.
According to Oladigbolu, the theme, which will run from 2021 to 2023, is succinct and appeals to the healthcare situation, and indeed diabetes care in Nigeria more than most countries of the world. He said about 5.8 per cent of adult Nigerians are said to be diabetic, saying the figure is a tip of the iceberg as it is estimated that two-thirds of the diabetes cases in Nigeria remain undiagnosed.
The number one community pharmacist in the country, noted that the situation of diabetes care in Nigeria is simply sub-optimal, ridden with inequality and lack of access to diabetes care, high cost of medicines, lack of quality assurance checks for service providers in the healthcare system and disorderly drug distribution system.
Oladigbolu however called on the Minister for Health, Dr Osagie Ehanire, to as a matter of urgency order the closure of all open drug markets in Nigeria, saying to do otherwise is to continue to play kites with the lives of ordinary Nigerians.
He also urged the Ministry of Health to call the National Health Insurance Scheme (NHIS), to order on the misinterpretation of her guidelines and the misdirection of her payment mechanism that has kept the coverage of health insurance in Nigeria at an abysmal level, while undermining the well being of people living with diabetes.
He added “community pharmacies are accessible to the people and their knowledge, skill and setups are suitable for diabetes education, ACPN has therefore commissioned a countrywide Community Pharmacy-Based Diabetes Education Programmes, which is a 12-month, individualized care programme based on Standardised Diabetes Self-Management Education Programme.
“This collaborative study will enrol over one thousand diabetic patients nationwide and it will be characterized by baseline clinical and pharmacotherapy assessments as well as assessment of baseline diabetes knowledge of these patients.
“Community pharmacists interventions {Diabetes Education/Pharmaceutical care} at the scheduled visit and the results of changes in clinical values and quality of lives of the patients at the end of the study. So, we look forward to collaboration from Pharmaceutical companies and other healthcare professionals for this important study”, he said.
Recently, a lady with the handle @Gentle Minic posted a message on Twitter saying “So after months of denial, I can still be diagnosed hypertensive at 27, I willingly accepted to live on drugs for the rest of my live two days ago, when my life almost slipped right before my eyes. Blood pressure kills. Check yours often”.
It is not surprising that after she dropped this tweet, she got so many retweets from friends and well-wishers advising and recommending food instead of the word ‘living on drugs’. It is indeed a sad one. For this not to be your story, scientists have found a new secret of healthy living, which could cut the risks of hypertension, diabetes and other related complications. The secret is nothing than eating fresh fruits and vegetables daily.
Some of the fruits for hypertension and diabetes patients
Blood pressure is the force of blood against the inner walls of your arteries. It has normal fluctuations throughout the day—falling when you’re relaxed or asleep, rising naturally in the morning, and increasing temporarily when you’re under stress, excited or exercising.
Doctors say you are at risk of hypertension if you eat a diet that’s low on natural produce and fiber or high in fat and salt, drink alcohol to excess, live with chronic stress or don’t get much physical activity.
“Some causes of hypertension cannot be controlled—including your genes and your race (African-Americans are at a higher risk). Aging also plays a role. Even if you do not have hypertension by age 55 to 65, your lifetime risk for developing it is a whopping 90 percent, says Samuel Durso, M.D., director of the Division of Geriatric Medicine and Gerontology at Johns Hopkins.
“Citrus fruits, including grapefruit, oranges, and lemons, may have powerful blood-pressure-lowering effects. They’re loaded with vitamins, minerals, and plant compounds that may help keep your heart healthy by reducing heart disease risk factors like high blood pressure”, he added.
Although, previous studies have advised against the consumption of fresh fruits in diabetics and non-diabetics, due the claims of their high sugar content, which could generally predispose people to diabetes and other related diseases.
In a 2013 study of 3,000 older people, published in the journal Neurology, Johns Hopkins researchers found that those taking diuretics, ARBs and/or ACE inhibitors had a 50 percent lower risk for Alzheimer’s disease.
Intensive treatment lowers blood pressure in African-American men.
Urban African-American men face a high risk for untreated hypertension—with fatal consequences. In a 5-year-long study of 309 African-American men ages 21 to 54, Johns Hopkins scientists found that those who consumed fruits like cucumber, citrus fruits, carrots, and spinach, had lowered blood pressure significantly.
However, according to the research conducted by scientists from the University of Oxford in the United Kingdom, published in the journal PLOS Medicine, which aimed at investigating the health effects of consuming fresh fruit in patients both with and without hypertension and diabetes, it found that people who did not have diabetes at the beginning of the study and consumed fresh fruit in high amounts had a significantly lower risk of diabetes.
Additionally, those who had diabetes at the beginning of the study and consumed high amounts of fruit had a significantly lower risk of dying from any cause, as well as a lower risk of developing cardiovascular complications.
More specifically, in comparison with the other study participants, those who consumed fresh fruit daily had a 12 percent lower relative risk of developing diabetes.
There is no gainsaying the fact that diabetes affects more than 420 million people worldwide and more than 29 million people in the United States alone.
According to the World Health Organisation (WHO), diabetes caused more than 1.5 million deaths in 2012. In the U.S., diabetes is a leading cause of death, accounting for almost 80,000 yearly deaths, according to the latest statistics from the Centres for Disease Control and Prevention (CDC).
The team leader Huaidong Du of the University of Oxford in the United Kingdom, said they examined the effects of fruit consumption on almost 500,000 people enrolled in the China Kadoorie Biobank national study. Participants were aged between 30 and 79 and lived in 10 different areas across China.
While the participants were clinically followed for approximately 7 years, 9,504 cases of diabetes were identified in participants who did not have diabetes at the beginning of the study.
The seeds are widely used in preparing the popular ogbono soup; but beyond this domestic use, Nigerian scientists have recently found that extracts of the African wild mango, possess anti-diabetics, anti-obesity, antimicrobial, antioxidant and GI properties.
The study, jointly conducted by researchers from the department of Medical Biochemistry, School of Basic Medical Sciences, College of Medical Sciences, University of Benin; and the department of Biochemistry, University of Benin, corroborated early studies on the potential industrial application of the African wild mango in food, cosmetic, and pharmaceutical products.
The research titled, “Effects of long-term oral administration of aqueous extracts of Irvingia gabonensis bark on blood glucose and liver profile of normal rabbits”, as published in the Journal of Medicinal Plants Research Vol. 6(13), monitored the body weight, blood glucose and liver function of normal rabbits at pre-determined intervals for 24 weeks. At the end of the period, it was found that body weight and fasting blood sugar were significantly reduced in the medicinal plant treated rabbits. While the sustained anti-obesity and hypoglycaemic effects, as well as the relative low liver toxicity of I. gabonensis bark extracts makes it an important candidate for the treatment of diabetes.
According to the lead author, A. A. Omonkhua, early studies have shown how different species of the African wild mango have proved effective in the treatment of ailments such as dysentery, diabetes mellitus and also used as analgesic. He noted that the hypoglycaemic effects of I. grandifolia have also been reported in normal rabbits and streptozotocin-induced diabetic rats.
The anti-diabetic effects of I. gabonensis seed extracts on type 2 diabetics was first reported by Adamson et al.; while seed extracts have also been reported to have hypoglycaemic effects on humans and on streptozotocin-induced diabetic rats .We have also observed the anti-diabetic effects of aqueous extracts of I. gabonensis bark on streptozotocin- induced diabetic rats, he asserted.
Description
Irvingia gabonensis is known by different names. Among the English speaking people, it is called African mango, African wild mango, sweet bush mango or simply bush mango; the Hausas call it goron or biri; Igbos call it ogbono; while it is known as oro in Yorubaland.
African mango tree is found throughout the tropical forests of Africa and is also cultivated on farms in central and western Africa. The tree grows 10 to 40m in height and has a flared base 3m in height. The dark green foliage is dense and the leaves are elliptical. The yellow to white flowers occur in bundles or clusters from February to March, and the almost spherical fruit appear during the rainy season from July to September. The tree reaches maturity and begins flowering at 10 to 15 years of age, while flowering and fruiting times vary according to geographic location.
The timber and wood of the tree are fine grained, hard, and durable. The ripe fruit is green while the edible mesocarp is soft, juicy, and bright orange. The mesocarp has a turpentine flavor and may taste sweet to slightly bitter. The seeds or kernels of the tree are classified as oil seeds.
Nutritional contents of the African mango
Nutritive value of the kernels per 100g edible portion, which corresponds to about 2918 kJ of energy, is as follows:
Fat 67 g
Carbohydrate 15 g
Protein 8.5 g
Water 4 g
Calcium 120 mg
Iron 2.4 mg
Besides the mentioned components, kernels of African mango contain traces of thiamine, riboflavin and niacin. The approximate fatty acid composition is myristic acid 33–70%, lauric acid 20–59%, oleic acid 1–11%, palmitic acid 2% and stearic acid 1%. The contained amino acids are reasonably balanced for human nutrition. Since lysine, tryptophan, valine, threonine, isoleucine and phenylalanine have high concentrations in the seed, first limiting amino acids are methionine and cysteine
Unlike the pulp of some other Irvingia specie, the pulp of the fruit of the African mango tastes juicy and sweet and is eaten fresh. Nutritive value per 100g edible portion of the fruit pulp, which corresponds to 255 kJ of energy is as follows:
Water 81 g
Carbohydrate 15.7 g
Protein 0.9 g
Fat 0.2 g
Phosphorus 40 mg
Calcium 20mg
vitamin C 7mg
Iron 2mg
The fruit pulp’s flavour components include zingiberene, cinnamic acid, dodecanal and dodecanol. This results in spicy-earthy, fruity, wine-yeast flavor notes.
Traditional uses of African mango
Ethno medicinal treatments utilise the bark, kernels, leaves and roots of the fruit for a variety of ailments. The bark is mixed with palm oil for treating diarrhoea. The shavings of the stem bark are consumed by mouth to treat hernias, yellow fever, and dysentery, and to reduce the effects of poison in French Equatorial Africa.
The antibiotic properties of the bark help heal scabby skin, and the boiled bark relieves tooth pain. The Mende tribe in Sierra Leone grinds the bark into a paste with water and applies the product to the skin for pain relief. In certain parts of Africa, the bark extract is ingested to produce an analgesic effect. The powdered kernels act as an astringent and are also applied to burns. The stems of the tree have been used as chewing sticks to help clean teeth.
African mango juice produces a quality wine at 8 per cent alcohol content after 28 days of fermentation. Additionally, the fresh bark has been used to alter the taste of palm wine.
The kernels of African mango are classified as oilseeds. The seeds are grounded into a paste, also known as dika bread, which is valued for its food-thickening properties. The resulting product is used in soups, stews, or sauces. The fat extracted from the kernel is similar to margarine or cooking oil. Flour may also be produced from the kernels.
Numerous studies exist on the potential industrial application of African mango in food, cosmetic, and pharmaceutical products. Agroforestry initiatives on phenotypic variation, amino acid profile, soil conditions and economic potential of the plant species document additional commercial interest. The oil from the kernel may act as a binder in food or pharmaceutical products or as an industrial gum. The pulp is used for making jam, jelly, and juice and is consumed as a dessert throughout western and central Africa. The leaves are used as food for livestock by farmers. The wood is used for making walking sticks and supports for thatched roofs.
Other health benefits of African mango
According to the researchers, a study on African mango revealed beneficial effects on diabetes and obesity as well as antimicrobial, antioxidant, and GI activity.
Diabetes
Although the study is limited, African mango supplementation in diabetic patients for over four weeks lowered blood glucose levels and normalised erythrocyte membrane ATPase activity. The ratio among the enzymes studied in diabetic patients was comparable to that of nondiabetic patients. A very similar study documents reduced plasma lipids in diabetic patients due to decreased low-density lipoprotein (LDL) plus very low-density lipoprotein (VLDL)-cholesterol and triglycerides levels. ATPase activity normalised and high-density lipoprotein (HDL) cholesterol was increased.
Obesity
Several potential mechanisms against obesity with African mango supplementation include: Inhibitory effect on the enzyme glycerol-3-phosphate dehydrogenase involved in converting glucose to stored fat; beneficial effect on the enzyme peroxisome-proliferator-activated receptor (PPAR)-gamma involved in adipogenesis and insulin sensitivity; upregulation of the protein hormone adiponectin, which enhances insulin sensitivity and endothelial function; and decreased leptin expression or enhanced leptin sensitivity (inhibits food intake and stimulates thermogenesis).
A 10-week, randomised, double-blind, placebo-controlled study of 102 overweight patients evaluated the effects of African mango seed extract on body weight and associated metabolic parameters. Patients received either 150 mg of African mango seed extract or placebo 30 minutes before lunch and dinner. Patients receiving the extract improved both weight reduction (body weight, body fat, waist circumference) and metabolic parameters (plasma total cholesterol, LDL cholesterol, blood glucose, C-reactive protein, adiponectin, and leptin levels).
A one-month, randomised, double-blind, placebo-controlled, crossover study examined the effects of African mango seed extract in 40 obese patients. 41 Patients were administered three capsules containing 350 mg of African mango seed extract (active formulation) or oat bran (placebo) three times daily 30 minutes before meals with a glass of warm water. Patients were on a normocaloric diet and were evaluated every week, as well as instructed to keep a record of food consumed.
At the end of the study, patients treated with the seed extract had reduced body weight, waist and hip circumference, and metabolic parameters (eg, total cholesterol, LDL cholesterol, triglycerides), and increased HDL cholesterol. Patients treated with the extract also reported reduced systolic blood pressure. Another 10-week clinical study treating patients with a formulation of two plant materials, African mango and Cissus quadrangularis, resulted in reductions in body weight and improved metabolic parameters.
Other pharmacologic activity
Analgesic
In a mouse study, the analgesic activity of a water extract from African mango stem bark was comparable with the narcotic analgesic morphine, while the ethanol extract was comparable with the nonnarcotic analgesic methimazole sodium.
Antioxidant
One study documents antioxidant activity in African mango seeds.
Antimicrobial
African mango leaf and root extracts have documented inhibitory activity against several bacteria and fungi. Potential mechanisms of action include membrane disruption by terpenoids and inactivation of microbial adhesion, enzymes, and cell envelope transport proteins by ellagic acid-like compounds.
Gastrointestinal
A methanol extract of African mango exhibited dose-dependent inhibition of indomethacin-induced gastric ulceration in mice. The antiulcer activity of several doses of the extract was comparable to that of cimetidine (50 mg/kg), and the extract also reduced gastric acid secretion and increased mucous secretion. Another animal study in mice administered African mango aqueous leaf extract reported decreased GI motility and GI protection against castor oil-induced diarrhoea.
Dosage
Clinical studies used dosage regimens of 150 mg of African mango seed extract 30 minutes before lunch and dinner or 1,050 mg 3 times daily 30 minutes before meals with a glass of warm water. Powders, liquids, and capsules are available from commercial manufacturers, with most common dosage regimens consisting of 150 mg of African mango twice a day with food.
References
The Internet Journal of Pharmacology,Vol.9(1): “Pharmacological effect of Irvingia gabonensis Leaf Extracts on cat blood pressure”, Nosiri, C; Hussaini, Abdu-Aguye,I; Abdurahaman, E.
Journal of Ethnopharmacology, Vol.45(2):”Analgesic effect of Irvinga gabonensis stem bark extract”.Chinedu O. Okoloa, Patricia B.Johnsona, Ezzel M.Abdu-Aguyea, Isa M.Hussaini
Journal of Medicinal Plants Research Vol.6(13) : “ Effect of long-term oral administration of aqueous extracts of Irvinga gabonensis bark on blood glucose and liver profile of normal rabbits”.Omokhua A.A, and Onoagbe I.O
-As Nigerians Join Global Community to Mark World Diabetes Day 2021
Image: Diabetesselfmanagement.com
Diabetes is a deadly disease that affects about 24 million Africans, among whom are 6 million Nigerians, according to World Health Organisation (WHO) latest statistics. It’s so bad that it ravages virtually all organs of the body, starting from loss of vision to dental problem, then kidney failure, cardiovascular disease, lower limb amputation, sexual dysfunction, among others, when not properly controlled. It is described as one of the largest global health emergencies of the 21st century.
This explains why diabetics have taken to the media to secure government’s attention in arresting their present predicament, as a good number of them are groaning under the heavy inflation in the country, which they said has financially incapacitated them from obtaining their anti-diabetes drugs and devices, which in turn could worsen their situation without proper access.
Pharmanewsonline interaction with some of these patients shows that there is a looming diabetes epidemic in the country, if the government does not swiftly swing to action regarding making access to diabetes medicines easier and cheaper for sufferers, as most of them are no longer adhering to their medications, due to increase in cost of pharmaceutical products.
Our findings align well with the views of Diabetes Control Media Advocacy Initiative (DICOMA) a Non-Governmental Organisation (NGO), which asserted that people living with diabetes are among the worst hit by the current inflation in the country, as many are unable to take their medications or follow necessary guidelines and routines to keep the disease in check. The COVID-19 pandemic and the attendant disruption it created, have also contributed negatively to this, as many bread winners lost jobs with the economic downturn.
I can’t afford daily test again due to hike in strips price- Obikoya
The story of Wale Obikoya, a 35-year-old male, who inherited the condition from his late father, is really pathetic. He told us how he has stopped checking his blood sugar regularly due to the hike in price of testing strips, which rose from N3,500 to N7000. Despite his deteriorating health condition, he still found it difficult to afford the device, talk less of medications, as he is being owed by his employers.
“I am a part time teacher by profession and I teach in different private schools, but it hasn’t been easy coping financially, because I have a family of four, myself, wife and two children to cater for with my meagre salary. The worst of it is that my school proprietors owe me, thus, affording my medications and devices is a huge challenge for me at the moment. Would appreciate if government can reduce the tariff on some of these drugs and devices to provide easy access for us to purchase”, he pleaded.
I almost got my limp amputated for lack of medications, says Timothy
Mrs Juliana Timothy, an elderly woman, who is a petty trader, is another patient who narrated her condition to Pharmanewsonline, when we visited her. She told us how she escaped limp amputation by the whiskers late last year, when she was diagnosed of diabetes. Thereafter, she explained how she been struggling with the management of the condition, as cost of drugs has gulped all her profits, while she is expected to visit the hospital once in two weeks for checkup and medications.
“Presently, I don’t even have any money again to buy drugs, as they are very expensive and my children have not been cooperating financially because they also have their challenges. It is only one, out of my nine children that supports me financially for my medications, whereas others are even looking unto me to assist them if I can. I think the government can come to our rescue, even for some of us who are elderly; they should create clinics where we can get these drugs freely or at subsidized rates”, she stated.
Experts affirm hike in anti-diabetes drugs, devices
In a chat with an Endocrinologist, Prof. Olufemi Fasanmade, from the University of Lagos, on the theme for this year’s World Diabetes Day (WDD), usually commemorated on every 14 November, which is “Access to diabetes care – If not now, when?” He concurred with the lamentations of diabetics on the surge in prices of their medications, saying it will cost a typical diabetes patient N5000 to N14000 to test his blood sugar in a month, as he needs to check once or twice a day.
DICOMA’s Trustee Chairperson, Dr Afoke Isiavwe, and Director of Communication Mrs Yinka Shokunbi, also affirmed this through their press statement, as they noted that children living with diabetes most of whom must be on regular insulin injection are also badly affected by the situation as many parents either reduce doses or stop administering injections as the cost of insulin, a vital component of diabetes management has risen by over 40% in the last six months. “A vial of insulin now costs between N6000 and N12, 000 in different parts of the country”.
Prof. Olufemi Fasanmade
Lifestyle management is key, says Fasanmade
Prof. Fasanmade, who appealed to government on behalf of diabetics to reduce duties on diabetes drugs, nonetheless pointed out that the solution to the condition lies with patients themselves, as they can work out the control of their glucose level at every point in time.
“So how can we cope with such cost? The simplest thing to do is to ensure that your blood sugar is so controlled, that you don’t need to check often. When your diabetes is well controlled, you don’t need to check every day, but if your diabetes has progressed to the extent that you are on tablets, you have anti-hypertensive, then you have to check very often. The only thing you can appeal is through the media for government to take away duties from diabetes medicines, because they are not manufactured in Nigeria”, he advised.
DICOMA harps on urgent govt’s intervention
DICOMA, therefore seeks urgent intervention from states and federal governments, saying the 2021 celebration of WDD should not just be a lips service, but practical steps should be taken to ameliorate the condition of people living with diabetes in the country, as it is done in other climes. They cited the examples of Cameroun and other African countries, where insulin has been made free for children and senior citizens, urging Nigeria to take clue from them.
The NGO’s representatives further expressed their alignment with the theme of the 2021 WDD, especially now that the cost of drugs and monitoring devices have gone far beyond the reach of the average person in the country that is living with diabetes. “We believe this year’s WDD should not be about speeches and other forms of social gatherings alone. The country must make conscious efforts to address the plight of people living with diabetes. It is time to review our policies and as a matter of urgency, introduce measures aimed at alleviating the plight of Nigerians suffering from diabetes.
“To this end we call on the government to, as a matter of urgency:Introduce policy and measures to drastically reduce the cost of anti-diabetes drugs and devices through zero import tariff and encouragement of their local production; provide free or subsidised insulin for children and the elderly; implement some of the already existing policies and guidelines for the management of diabetes in Nigeria; increase awareness for diabetes education and enlightenment.
“DICOMA also calls on state governments, to commence immediate campaign for diabetes prevention and control, beginning from the 2021 WDD, while healthcare providers and other stakeholders should also intensify their efforts in screening for diabetes and providing adequate information to assist people living with diabetes on the basic management of the disease, and also assist the general public in recognising the signs and symptoms of the condition”, they stated.
The leadership of the Clinical Pharmacists Association of Nigeria (CPAN) has lauded the decision of Federal Government of Nigeria and the National Primary Healthcare Development Agency (NPHCDA) to include community pharmacies as part of approved vaccination centres for COVID-19 vaccination in the country.
The group described the inclusion plan by the Presidential Steering Committee (PSC) on COVID-19 as highly commendable, as the citizenry will be the greatest beneficiaries.
Recalled that during the week. the Secretary to the Government of the Federation, and Chair, Presidential Steering Committee on COVID-19, Boss Mustapha, and Executive Director/CEO, NPHCDA, Dr Faisal Shuaib, had at different times during the Conference on Health Advances Innovation and Research (CHAIR) organised by the management of Nigerian Institute of Medical Research (NIMR), mentioned the plans by the government to expand vaccination centres beyond public facilities, to pharmacies, private hospitals and other institutions
They hinged the vaccination expansion initiative on the inability of public healthcare team to cater for the healthcare needs of the Nigerian populace, as 70 per cent of Nigerians access their healthcare through private facilities.
In a statement issued to Pharmanewsonline, signed by CPAN National Chairman, Dr Joseph Madu, he noted that community pharmacists are usually the most accessible trained healthcare professionals in the community, and they are usually utilised by most members of the public as first point of call on health matters.
He explained that any policy to include community pharmacies in primary healthcare services such as COVID-19 vaccination for immunisation purposes is highly commendable.
According to him, “the use of community pharmacies as vaccination centres is not new to the world as this is the norm in most countries’ with good health indices such as the US and the UK. The use of community pharmacies as vaccination centres (including for COVID-19) by countries such as the US and UK, greatly explains why such countries have brought the pandemic to their knees.
“CPAN strongly believes that this singular decision of the FG, to use community pharmacies and other private healthcare facilities as vaccination centres will go a long way in exterminating the pandemic in the country.
“People can now walk across to the nearby community pharmacies in their neighbourhood to get vaccinated against COVID-19, once the decision is implemented”, he stated.
Another advantage, he said is that they will not require a prior appointment to consult with the community pharmacists.
Furthermore, he maintained that the community pharmacists are highly trained healthcare personnel on drug matters, and their proximity to the members of the community in which they practice, as well as trust by the community on the pharmacist can also assist in educating the members of the public against false information and myths surrounding the COVID-19 situation.
He expressed optimism that the FG & NPHCDA will extend the use of community pharmacies as vaccination centres to other vaccine preventable diseases and not just COVID-19, as that is in line with international best practices.
Kaduna State Government says it has trained 558 health care providers and 1,156 community volunteers in Community Infant and Young Child Feeding (C-IYCF) services.
Hajiya Saratu Musa, the state’s Nutrition Officer, disclosed this on Tuesday at a two-day meeting to conduct situation analysis of Maternal, Infant and Young Child Nutrition (MIYCN) in the state.
The News Agency of Nigeria (NAN) reports that C-IYCF is a preventive approach that targets child nutrition in the first 1,000 days of life.
Musa, represented by Mr. Adams George, Assistant State Nutrition Officer, said the care providers and volunteers trained on C-IYCF from Jan. to Sept. 2021, were part of the state’s nutrition intervention programme.
She noted that the C-IYCF personnel were trained in 22 Local Government Areas (LGAs), with Kaduna North LGA was outstanding.
Musa said World Health Organisation (WHO) reports released in June 2021 noted that globally in 2016 an estimated 155 million children under the age of five were suffering from stunting, while 41 million were overweight or obese worldwide.
“Nigeria has the second highest burden of stunted children in the world, with a national prevalence rate of 32 per cent of children under-five.
“An estimated two million children in Nigeria suffer from severe acute malnutrition (SAM), but only two out of every 10 children affected is currently reached with treatment.
`Nutrition situation of children and women in Kaduna state is of public health concern, malnutrition accounts for more than 50 per cent of under-five mortality.
“According to Nigeria Demographic and Health Survey (2018 NDHS), M-IYCF feeding practice has remained unsatisfactory with the rate of timely breastfeeding initiation as low as 35.9 per cent.
“Only 27.2 per cent of children exclusively breastfed and only 12.7 of children age six to 23 months were fed appropriately,” she said.
Musa, however, said it was encouraging that the prevalence of moderate and severe underweight among children under-five years dropped from 57.6 per cent and 36.9 per cent (NDHS 2013) to 22.1 and 7.6 per cent (NDHS 2018), respectively.
“In efforts to tackle malnutrition in Kaduna, Community Management of Acute Malnutrition (CMAM) fully commenced in 2017 in two LGAs of the State and Scaled-up to 16 LGAs by 2021.
“We have 78 Primary Health Centres providing Outpatient Therapeutic Programmes (OTP) to treat Community Management of Acute Malnutrition (CMAM) across 16 LGAs, with 17 secondary health facilities as stabilisation centres.
“We also have 100 health facilities providing maternal infant and young child nutrition across the state’s 255 wards providing community maternal infant and young child nutrition services,” she said.
Musa said Kaduna State Ministry of Health was committed to improving general well-being and ensuring better health outcomes of the people, including enhancing their nutritional status, especially for the most vulnerable groups, women and children.
Also, ANRiN Project Manager, Dr Zainab Muhammad-Idris, said the objective of the meeting was to ensure and provide viable steps in decreasing the number of malnourished groups which cut across pregnant and lactating mother and children below five years.
She said that women, children and other vulnerable groups constituted the largest number of victims of malnutrition in the state.
NAN reports that UN Children’s Fund (UNICEF) supported the programme aimed at reviewing the situation of MIYCN in Kaduna State that would inform adaptation of the MIYCN national policy in the state. (NAN)
Pharm. Tunde Oyeniran, president, Society for Pharmaceutical Sales and Marketing of Nigeria (SPSMN), second from left, announcing the winners at the raffle draw.
As part of their activities at the just concluded 94th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN), held in Port Harcourt, Rivers State, Ranbaxy Nigeria – a Sun Pharma Company, organised a raffle draw to reward customers who made purchases at their exhibition stand.
The raffle draw, which was witnessed by most of the conference delegates and participants, produced three winners, namely, the star prize award, which was a brand new “Rite Tec 3.5 Litres Air Fryer” and consolation prizes for the first and second runners up.
Presenting the award, the Group Product Manager, Ifeanyi Offor, appreciated the customers for their continuous patronage and assured delegates that SUN Pharma is committed to providing quality medicines and will continue to reach and touch lives in Nigeria.
He congratulated the winners of the raffle draw and encouraged them to do better in terms of patronage as they collectively continue to build the Ranbaxy – Sun Pharma Company brand into a world-class entity.
Conducting the draws, President of the Society for Pharmaceutical Sales and Marketing of Nigeria (SPSMN), Pharm. Tunde Oyeniran, urged customers to continue to keep faith with the Ranbaxy/Sun Pharmaceutical brands, adding that in doing so, they are also creating a win-win scenario for themselves.
He also commended the management and staff of Ranbaxy – Sun Pharma for making their presence felt at the ongoing conference, despite the huge resources it had to put together to ensure the entire process went well.
The Star Prize Winner was Pharm. Uche Onyekakie of Tugak Pharmacy, Port Harcourt, while the First Runner-Up was Pharm. Chioma Chikezie of Chy Walter Pharmacy, Enugu. The Second Runner-Up was Pharm. Matilda Odo of Chidinma Pharmacy.
Other Ranbaxy staff present at the event include Pharm. David Ayele, ethical regional sales manager South-South; Mr Glory Aizenabor, OTC regional sales manager for South-East and other company sales representatives.
The Nigeria Centre for Disease Control (NCDC) said that Nigeria recorded 65 additional cases of COVID-19 infections and eight COVID-19 related deaths on Wednesday.
The NCDC made the disclosure in its daily COVID-19 report on Thursday morning .
The News Agency of Nigeria (NAN) reports that the 65 additional cases reported on Wednesday indicate an increase from the 64 cases reported in the country the previous day.
The public health agency noted that with the new fatalities recorded, the death toll from the virus now stood at 2,914.
It also revealed that the total infection from the pandemic currently stood at 212,894 while a total of 204,675 Nigerians had been discharged across the country.
According to the agency, Plateau topped the infection chart with 22 cases, FCT followed with 21, North-central and Rivers, South-south reported 12 cases each.
Bauchi State recorded four cases, Lagos had two cases while Kaduna, Bayelsa, Edo, Jigawa reported a single case each while the states of Delta and Sokoto registered zero cases on Wednesday.
It noted that a multi-sectoral national emergency operations centre (EOC), activated at Level 2, continues to coordinate the national response activities.
According to it, the country currently has 5,297 active coronavirus cases, while a total of 3,392,457 blood samples have been tested since the pandemic began across the country. (NAN)(www.nannews.ng)
The International Committee of the Red Cross (ICRC) has developed a mobile tablet fitted with an electronic application to enable healthcare workers to diagnose and treat common childhood diseases.
Mr Marco Landi, ICRC, Project Manager of Algorithm for the Management of Childhood Illness (ALMANACH) said this in Abuja on Wednesday at the digitising healthcare photo exhibition on lifesaving technology in the North East.
According to him, the digital device, called ALMANACH is an innovative, user-friendly mobile application that provide accurate and specific support to health workers for clinical decision making.
“ICRC is an impartial, neutral and independent organisation whose exclusively humanitarian mission is to protect the lives and dignity of victims of armed conflict and other situations of violence and to provide them with assistance,’’ he said.
Landi said that ALMANACH, had made it possible for healthcare workers to diagnose and treat common childhood diseases in children less than five years old in Adamawa.
He said that more than 800,000 children under five years in Adamawa need essential health care.
“The state is one of the three states in the North East hit hard by the ongoing armed conflict and has had a devastating effect on the healthcare system in the region.
“ALMANACH was launched in Adamawa in 2016 in 12 health facilities and is currently being used by 412 facilities across the state.
“The device, which is quite user-friendly is an initiative of ICRC, the Swiss Tropical and Public Health,’’ Landi said.
He said that the core objectives of the project was to ease and give proper access to diagnose children illness from zero to five years.
According to him, the core objectives of the project is to give direct and accurate data in diagnosing a child with the advantage of getting quick result.
He said that the project was not introduced to substitute the clinical skills of healthcare workers, but to make them use their skills better.
“We want a better diagnosis to give children better treatment and fast,’’ Landi said.
He said the device would give health workers the chance to focus on the patient instead of trying to follow unbelievably complex algorithm.
According to him, the device has all the guidelines in the tablet with the latest information and most updated.
He said that once the physical examination was over, all the data would be digital, this would help to avoid the lengthy process of putting them on paper for summary.
“This gives us the possibility of analysing the data quality in real time when internet is available.
“And we have been generating in the past three years huge stream of information.
“The information, we believe think can be very useful both for epidemiological surveillance in the short term, and for the medium and long term planning for health resources,’’ Landi said.
Dr Suleiman Bashir, Adamawa State Primary Health Care Development Agency (ADSPHCDA) Chairman, said that if the project would be sustained, many lives would be saved.
Bashir said the device would help generate accurate data and improve the quality of counselling.
He said if the device would be properly utilised, it would improve the quality of healthcare in Nigeria.
Bashir called for partnership to sustain the project and achieve its objective.
According to him, the project is among the best so far designed to make primary healthcare service simple and accurate.
He said if properly used, “the device has a lot of advantages to the state and the country to achieve universal health coverage.” (NAN)
Zipline, the global leader in instant logistics, for Pfizer Inc. and BioNTech, has announced it successful completion of the first long-range drone delivery of authorised mRNA COVID-19 vaccines, requiring ultra-cold-chain in Ghana.
In a press release made available to Pharmanewsonline on Thursday, Pfizer Inc. revealed that the collaboration of the companies, which worked together earlier this year to develop and test an end-to-end vaccine delivery solution, will allow for the distribution of tens of thousands of doses of the Pfizer-BioNTech COVID-19 Vaccine in Ghana, pioneering a new model for vaccine distribution.
In addition to financial support for the pilot programme, the document disclosed that Pfizer and BioNTech provided technical assistance and know-how specific to the management and storage of the Pfizer-BioNTech COVID-19 Vaccine at -90°C to -60°C. This partnership has paved the way for drone deliveries of mRNA vaccines.
The companies noted that they share a goal to help ensure the safe and equitable distribution of COVID-19 vaccines. “Pfizer and BioNTech have committed two billion doses of their COVID-19 vaccine to low- and middle-income countries through 2022 and are actively working on collaborating with both public and private organisations to accelerate the vaccine rollout worldwide.
“To date, the Pfizer-BioNTech COVID-19 Vaccine has reached 2 billion vaccines to 155 countries and territories in every region of the world, including through its agreement with COVAX.
“Nearly 175,000 COVID-19 vaccines from multiple manufacturers have been distributed across Ghana to-date by Zipline, the first company to do so through an autonomous aircraft at national scale.
“Zipline plans to distribute millions more as supply becomes available. Through this partnership, Pfizer, BioNTech and Zipline have brought together their expertise and capabilities to help advance more equitable vaccine distribution”, the statement emphasised.
“Delivery to people in remote and hard-to-reach places is a primary challenge for global vaccination,” said Keller Rinaudo, co-founder and CEO of Zipline. “In partnership with Pfizer and BioNTech, we have created a solution to address this potential pain point head on. Together, we are working to help transform vaccine distribution into a more effective, equitable process.”
Making COVID-19 vaccines accessible to an entire country’s population presents logistical challenges for many governments and healthcare organizations, particularly in low- and middle-income countries. Zipline is helping to address these challenges by implementing an end-to-end distribution model that safely delivers any COVID-19 vaccine to all corners of a country through its autonomous aircraft.
“Pfizer has a history of investing with partners to improve access to medicines and vaccines in the most remote areas of the world,” said Caroline Roan, Chief Sustainability Officer, Senior Vice President, Global Health and Social Impact, Pfizer Inc. “We are proud of this collaboration with Zipline to implement breakthrough solutions that help advance equitable access to COVID-19 vaccines, particularly for hard to reach and underserved populations.”
“The global distribution of COVID-19 vaccines requires a coordinated effort,” said [BioNTech representative]. “This collaboration between Pfizer, BioNTech and Zipline showcases our collective commitment to pioneering new solutions that can help address COVID-19 vaccine access challenges and help put an end to this pandemic.”
Olayinka Subair, Pfizer Cluster Lead, West Africa said “Our focus is always on the patients as we deploy resources to bring treatments that extend and significantly improve their lives. We consistently seek to collaborate with stakeholders to support and expand access to reliable, affordable health care in communities all around.“
“At this time of extraordinary focus on science and dedication to patients, the Pfizer-BioNTech COVID-19 Vaccine, like all COVID-19 vaccines on the market, requires storage and transportation in controlled temperature conditions. Distributing these types of products rapidly and at national scale has no precedent in modern public health.
Pfizer-BioNTech and Zipline has successfully tested the end-to-end supply chain from Pfizer’s Puurs facility in Belgium to a last-mile health post in rural Ghana. By uniting transformational technology, cutting-edge science and indomitable human spirit, Pfizer is pioneering biopharmaceutical innovations to do more than just treat difficult diseases – we’re opening new worlds of medical possibilities in support of our purpose: Breakthroughs that change patients’ lives. And we’re applying equal parts intelligence, passion and ingenuity to ensure these breakthroughs are accessible to all.”
Zipline, Pfizer and BioNTech tested and validated the end-to-end model for delivery of mRNA vaccines with ultra-cold-chain requirements, and Zipline will now utilize it to distribute Pfizer-BioNTech COVID-19 Vaccines, as well as COVID-19 vaccines from all manufacturers, to regions across Ghana. The companies have detailed the learnings in an executive summary and a separate white paper.
Mazi Sam Ohuabunwa, presenting the handover document to the new PSN President, Prof. Cyril Usifoh.
The Immediate Past President of the Pharmaceutical Society of Nigeria (PSN) Pharm. (Mazi) Sam Ohuabunwa, has officially handed over the leadership baton of the Society to the newly elected president, Prof. Cyril Usifoh, on Thursday, at the National Secretariat, Anthony Village, Lagos.
Ohuabunwa, who expressed his delight in having an ideal pharmacist as his successor, said unlike some predecessors who still wish to linger in office for sometime after the expiration of their tenure, noted that he doesn’t have such ambition, as he is eager to allow the new president commence his administration in fullest without any obstruction.
He appreciated God for His benevolence in completing his tenure successfully, although he might not have achieved everything he wished to have attained for the profession, but he and his team did their best.
Presenting the handover note to the new president, he counselled him to embrace the constitution in all his dealings for the profession, as well as do everything with Godly reverence and a sense of duty to the profession.
He said: “I feel highly pleased and it doesn’t happen often that you are happy to be succeeded. There is always this feeling that you should be in lure of office that you should stay one month or thereabout in office more. But for me there is nothing like that, because I’m always running and whenever I leave, I’m usually begged to come back, but I don’t always return because there is always something ahead of me to pursue.
“So I’m glad God granted me the grace to finish well. I thank God also for keeping us to finish the three years in sound health for running the profession very well. We might not have achieved everything we wanted but we tried.
“More importantly, that people succeeded you and you are wondering if that is the best you could have. To be sincere, there were four gentlemen running the race, and any of them could be the president, but God in His infinite mercy had chosen whom I believe is the best among them all. For me it gives me joy because I’m proud to say I’m succeeded by so so and so, who already had cut for himself a niche in the field of Pharmacy, which is the academia.
“My advice to him is to be even-handed, to show love, to follow the constitution and to trust God. He should do things out of fear of God and out of love for the profession. He shouldn’t worry about who claps for him and who doesn’t. There is a price for leadership because not everybody will support you. Even because of what you are doing well, some people are going to be opposed to you because you are doing well, just for being jealous. He should rise above that and he will be successful. He should use all the resources at his disposal’, the former president stated.
In his response, Prof. Usifoh thanked God for the privilege to serve in such capacity, saying he will commence his administration with a retreat for NEC members for proper mapping out of strategies for their tenure.
For pharmacists whose candidates didn’t emerge as president, he assured them of an all inclusive administration that no one is going to be left out.
“It is the Lord’s doing that I’m elected and handing over has been done. It is actually a call to service. I have served in various capacity and I’m fortunate to have team members who are willing to serve. We are going to hit the ground running and I’m going to start with a retreat, to enable me educate NEC members on how we are going to work and brainstorm on the blueprint of what we want to do.
“To me we are all victors, we are going to work together as men of honour. It is a joint work, all of us we work together, it’s a Pharmacy family..
-Says 6 Million Nigerians, 24 Million Africans, are Diabetic
Ahead of the World Diabetes Day, which is 14 November, the World Health Organisation (WHO) has raised alarm on the deteriorating health condition of many Africans living with disease, saying Africa’s death rates from COVID-19 infections are significantly higher in patients with diabetes, according to a preliminary analysis presented today by the international agency.
The apex health institution, in a statement released on Thursday identified the sharp increase in Africa’s diabetes rates and poor access to vaccines as major causes of complications in the management of COVID-19 pandemic in the region.
“COVID-19 is delivering a clear message: fighting the diabetes epidemic in Africa is in many ways as critical as the battle against the current pandemic,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “The COVID-19 pandemic will eventually subside, but Africa is projected in the coming years to experience the highest increase in diabetes globally. We must act now to prevent new cases, vaccinate people who have this condition and, equally importantly, identify and support the millions of Africans unaware they are suffering from this silent killer”.
The health global agency asserted that diabetes impairs the body’s ability to produce or process insulin, a substance essential to counteracting a dangerous rise in blood sugar. The disease causes inflammation and poor blood circulation, both of which increase the risk of complications, including death, from COVID-19.
A recent WHO analysis evaluated data from 13 countries on underlying conditions or comorbidities in Africans who tested positive for COVID-19. It revealed a 10.2% case fatality rate in patients with diabetes, compared with 2.5% for COVID-19 patients overall. The case fatality rate for people with diabetes was also twice as high as the fatality rate among patients suffering any comorbidity. In addition to people with diabetes, the three most frequent underlying conditions included patients with HIV and hypertension.
The countries contributing data to the analysis were Burkina Faso, Chad, Cote d’Ivoire, Democratic Republic of the Congo, Eswatini, Guinea, Namibia, Niger, Rwanda, Senegal, Seychelles, Sao Tome and Principe and Uganda.
An estimated 24 million people are living with diabetes in Africa in 2021 according to the International Diabetes Federation and the continent is expected to experience the highest increase in diabetes globally, with the number of Africans suffering from the disease predicted to rise to 55 million by 2045, an increase of 134% compared with 2021. Africa is the region with the highest number of people who do not know their diagnosis – an estimated 70% of people with diabetes do not know they have the disease.
“Health officials in Africa should take advantage of the growing availability of low-cost rapid diagnostic tests to routinely test patients in diabetes centres to ensure early detection and proper care,” said Dr Benido Impouma, Director, Communicable and Noncommunicable Cluster at WHO Regional Office for Africa. “These centres also can be key venues for vaccination.”
Since the early days of the pandemic, people with diabetes in countries around the world have been prioritized to receive COVID-19 vaccinations. Africa has faced challenges in this strategy.
Access to vaccines remains poor. Thus far, only 6.6% of the African population is fully vaccinated against COVID-19, compared with about 40% globally. Data from 37 countries indicates that since March 2021, over 6.5 million COVID-19 vaccine doses have gone to Africans with comorbidities, representing 14% of all doses administered so far. Efforts to prioritize people with comorbidities, like diabetes, are accelerating with about half of those 6.5 million doses administered in just the last couple of months. However, there is still a lot more work to be done to ensure people at high risk receive the vaccines they need.
“Nine months since COVID-19 vaccination campaigns began in Africa, we are still nowhere near where we need to be with protecting our most vulnerable,” Dr Moeti said. “There is an urgent need to step up vaccination and other key services to people at high risk, including those with diabetes.”
There are two main types of diabetes: type 1 caused by a condition early in life that damages the pancreas and impairs insulin production; and type 2—which is linked to poor diet, obesity and lack of exercise—where the body struggles to process insulin. About 90% of diabetes cases globally, and the vast majority in Africa, are type 2, with rising rates in Africa attributed to the same poor diets and sedentary lifestyles causing a surge in type 2 diabetes around the world. In addition to COVID-19 risks, diabetes can also increase risk of heart attack, stroke, kidney failure, lower limb amputation, visual impairment, blindness and nerve damage, including erectile dysfunction.
“All Africans at risk of diabetes must have access to testing,” Dr Moeti said. “We can also stop diabetes from claiming more lives by promoting healthy, affordable diets and regular exercise.”
During the COVID-19 pandemic, access to diabetes care has been severely disrupted in the African Region. Lockdowns to limit the spread of COVID-19, for example, have impeded access to health care and the basic elements of proper disease management, such as routine glucose monitoring and eating a healthy diet.
To improve equitable access to quality diabetes care, WHO launched the Global Diabetes Compact in April, 2021. This builds on work in recent years to rollout the WHO Package of Essential Noncommunicable Disease (WHO PEN) interventions for primary health care in low-resource settings. So far 21 African countries have started using this package. Benin, Eritrea, Eswatini, Lesotho and Togo have achieved national expansion covering all primary health care facilities.
WHO held a virtual press conference today facilitated by APO Group, Dr Impouma was joined by Professor Maïmouna Ndour Mbaye, Head of the Internal Medicine unit, Cheikh Anta Diop University of Dakar and Director, National Diabetes Centre, Senegal, and Mr Greg Tracz, Chief Executive Officer, Diabetes Africa.
The World Health Organisation says more Nigerians know about COVID-19 than Tuberculosis even though TB has been in the country for about 129 years.
WHO’s National Professional Officer TB/HIV, Nigeria Country Office, Dr. Amos Omoniyi, said this on Wednesday in Abuja, on Day 2 of the 2021 National TB Conference.
The conference was organised by Stop TB and the National Tuberculosis and Leprosy Control Programme of the Federal Ministry of Health in collaboration with other partners.
The News Agency of Nigeria, reports that a 2021 publication from the WHO reveals that for the first time in over a decade TB deaths had increased.
The publication said it was due to reduced access to TB diagnosis and treatment in the face of the COVID-19 pandemic.
Omoniyi added that there was a need for all to invest more in TB awareness in the country.
He said that disseminating tuberculosis awareness messages to hard-to-reach communities in the country in different local languages would be effective in the control of TB.
Omoniyi added that Political will was extremely important in the fight against Tuberculosis in the country.
“We need to continue to strengthen policies and programmes that can promote the eradication of Tuberculosis in the country,” he added.
According to Mrs. Elsie Ilori, Director of Disease Surveillance Department, Nigeria Centre for Disease Control, COVID-19 response has challenged the health system in many ways in the country.
Ilori added that there was a need to document lessons learnt from the COVID-19 pandemic to help strengthen the capacity and resilience of the country’s health system to respond to future epidemics and pandemics.
According to her, as an agency with the mandate to detect, control, and respond to infectious disease outbreaks in Nigeria, the NCDC will continue to partner with Stop TB Nigeria to ensure the elimination of TB.
Prof. Abba Abdullahi of College of Medical Sciences, Kaduna State University, stressed the need for the country to focus on research and innovation toward getting vaccines, new drugs, rapid diagnostic tests and treatment for TB in the country.
Dr. Mustapha Gidado, the Executive Director of KNCV Tuberculosis Foundation, said that TB could be eliminated in the country and globally notwithstanding all challenges.
Gidado noted that government, partners, and the media should remain determined to fight the elimination of TB in the country.
“We all have critical roles to play,” he added.
NAN reports that the National TB Conference hopes to create an opportunity to learn lessons from experiences within and from other countries.
It intends to come up with strategies to address TB control during the current and future pandemics in the country.
All frontline workers in the National Health Service in England will need to be fully vaccinated against COVID-19 from April 1 or lose their jobs, Health Minister Sajid Javid said on Tuesday.
“Having considered the… advice of my officials and NHS leaders including the chief executive of the NHS, I have concluded that all those working in the NHS and social care will have to be vaccinated,” he told parliament.
The government had already announced that all care home workers will need to have had both vaccines from November 11 but were waiting on the findings of consultation before extending it to all NHS frontline staff.
“Our six-week consultation received over 34,000 responses,” said Javid.
“The scales clearly tip to one side. I’m mindful of not only our need to protect human life but the imperative to protect the NHS,” he added.
“The weight of the data shows our vaccinations have kept people safe and they have saved lives and that this is especially true for vulnerable people in health and care settings.”
The move comes at a time when the publicly-funded health service is already facing a huge waiting list due to a dramatic reduction in appointments during the pandemic.
The NHS, which is funded from general taxation and National Insurance contributions, is Europe’s biggest employer and one of the biggest in the world, with some 1.3 million staff.
Around 90 percent of NHS staff have received at least two doses of the COVID-19 vaccine, although the figure is closer to 80 percent in some areas, said Javid.
This means there are around 80,000 to 100,000 NHS workers in England who are unvaccinated, raising fears about how the service will cope if they lose their jobs.
“The NHS is under the most intense pressure this winter already, we know the waiting lists are at close to 6 million,” said Labour’s health spokesman Jonathan Ashworth.
“There will be anxiety… that a policy, however laudable in principle, could exacerbate some of these chronic understaffing problems.
“We simply cannot afford to lose thousands of NHS staff overnight,” he added.
The Federal Executive Council has approved three contracts for the procurement of equipment for cancer management at the Federal Medical Centre, Kastina and Usman Dan Fodiyo University, Sokoto.
Minister of Health, Dr. Osagie Ehanire, briefed State House correspondents after a virtual FEC meeting presided over by Vice President Yemi Osinbajo on Wednesday at the Presidential Villa, Abuja.
He said, “FEC today considered three memos from the ministry of health—all of them were in respect of procurement.
“First was a memo from Federal Medical Centre, Kastina, for an Oncology and Radiotherapy Centre to be able to handle cancer cases.
“The projected award was to a company for N1.23 billion with a completion period of 42 weeks.’’
Ehanire said that the project would be executed by a Nigerian company.
According to him, the second and third memos are for re-equipping UDUS which is one of Nigeria’s Centres of Excellence for managing cancer.
“Their equipment is old and broken down; the most important is the leading accelerator which is going to be replaced and the Magnetic Resonance Imaging (MRI) machine which will also be replaced.
“The MRI machine at the cost of N440.4 million from the budget appropriation to replace the old dysfunctional one and the linear accelerator at 887.6 million from the Special Intervention Fund,’’ he said.
The Chief Medical Director, Living Standard Hospital, Benin, Dr. Jide Owonala, says ischemic heart disease can lead to death, if not properly managed.
Owolana spoke in an interview with the News Agency of Nigeria on Tuesday in Benin.
He defined Ischemic heart disease as the damage or disease in the heart’s major blood vessels, noting that the disease was usually a result of a build-up of plaque, which caused coronary arteries to narrow, limiting blood flow to the heart.
The oncologist said Ischemic heart disease was very rare and has fewer than 100 cases in Nigeria, adding that treatment could help but could not be cured.
He added that “coronary artery disease can range from no symptoms to chest pain and heart attack.
“When plaque builds up, it narrows the coronary arteries and decreases blood flow to the heart.
“Eventually, the decreased blood flow may cause chest pain (angina), shortness of breath, or other coronary artery disease signs and symptoms.
“A complete blockage can cause heart attack,” the chief medical director said.
He said that coronary artery disease often develops over decades and that one might not notice the problem until there was a significant blockage or a heart attack.
Owolana said that the disease could be prevented if a person kept a healthy lifestyle, avoid smoking and drinking.
-As Oladigbolu Congratulates Community Pharmacists on the Feat
L-R: Director of Administration, NIMR, Alh. A.S Yunusazazzau; Director General NIMR, Professor Babatunde Salako; Mukhtar Mohammed, secretary of the Presidential Steering Committee on COVID-19; and Prof. Ravindra Gupta, University of Cambridge, chairman of the occasion.
In what appears to be the long-awaited response to community pharmacists’ quest to be part of the COVID-19 vaccination exercise, the Federal Government has disclosed her readiness to include pharmacies, private hospitals, all government health facilities, and other institutions as centres for vaccination, in order to expand COVID-19 vaccines roll out in the country.
Secretary to the Government of the Federation, and Chair, Presidential Steering Committee on COVID-19, Boss Mustapha, made the disclosure on Tuesday, while fielding questions from journalists at the Conference on Health Advances Innovation and Research (CHAIR) organised by the management of Nigerian Institute of Medical Research (NIMR). He asserted that since 70 per cent of Nigerians access their healthcare through private facilities, government won’t be able to reach 30 per cent of its population with vaccination if it is restricted to government facilities only.
This comes as the National Chairman, Association of Community Pharmacists of Nigeria (ACPN) Pharm. Adewale Oladigbolu, felicitated with community pharmacists across the country for a landmark achievement, in the actualization of their much-anticipated response from the Federal Government. Although, he noted that the information was yet to get to his office, but he assured his members that since it is coming from the presidential steering committee on COVID-19 and the NPHCDA, they should be optimistic about the implementation.
Oladigbolu, who spoke with Pharmanewsonline in a telephone chat on the development, expressed his gratitude to the Federal Government on her consideration of pharmacists’ plea, while also congratulating Nigerian citizens for improved access to vaccines, which will definitely improve healthcare outcomes in the country.
Cross section of participants at the conference
Mustapha, who was the special guest of honour at the 10th CHAIR, represented by Mukhtar Mohammed, secretary of the Presidential Steering Committee on COVID-19, said it has become imperative for the Federal Government to partner private sector in order to have effective and robust vaccination coverage for Nigerian citizens.
“Let me start by saying that 70 per cent Nigerians get their healthcare through the private facilities. And discussions have started, that even if we are to float all the public healthcare facilities with vaccines, we will still not reach 30 percent coverage. Therefore, we need to work with the private sector to have more innovated approach to ensure that people can access these vaccines through whatever mechanism.
“The government has started by issuing the directive of vaccine mandate to Federal Government workers by December 21. That is just the beginning, as we will be expanding vaccination centres to private health facilities, pharmacy stores, markets, parks, etc, to ensure that people have ensure access to vaccine wherever they are”, he stated.
Earlier in his keynote address, Executive Director/CEO, National Primary Healthcare Development Agency (NPHCDA) Dr Faisal Shuaib, had intimated the scientists on the progress made so far by the agency in vaccination coverage in country, as the nation aims at vaccinating 50 per cent of its eligible target population before Christmas, 2021. For this target to be actualised, he revealed that selected pharmacy stores will be included to the list of vaccination centres, in addition to private hospitals and other designated venues for the exercise.
Explaining other strategies to be deployed by the agency to meet the December target, out of the total population of Nigeria which is 216,797,455, he said while total eligible population is 111,776,503, only 5,573,349, people have been vaccinated with at least 1 dose, left with additional reach of 50 per cent target before Christmas which is 50,314,903.
“We are implementing 5 approaches to achieve optimization of process in developing the approach for COVID-19 vaccination roll-out. These include: Vaccination in primary, secondary and tertiary facilities; Expansion to private health facilities and corporate institutions (public and private, including selected pharmacy stores); Establishment of mass vaccination sites; Leveraging fixed and outreach R.I sessions; and Establishment of temporary posts – drive-throughs, community pop-ups”, he disclosed.
Speaking on the theme of the conference: “COVID-19 Pandemic: Consolidating the Gains and Addressing the Shortfalls”, Director General NIMR, Professor Babatunde Salako, applauded the efforts of NIMR and other institutions in mitigating the effects of the pandemic , while raising concerns on the direct and indirect impacts of the disease on Nigerians.
He drew attention of the audience to effect of the pandemic on other disease areas, especially in Nigeria that bears the highest burden of tuberculosis, HIV and malaria. The control of these diseases has indeed suffered a setback over the past year due to the shift on public health focus to the COVID-19. In addition, the indirect effect on mental health has also emerged.
“We must continue to pay particular attention to these disease of poverty both at individual researcher and government levels in order to alleviate the suffering of those afflicted with them, otherwise the gains of COVID-19 control may be lost to upsurge in HIV, malaria and tuberculosis”, he emphasised.
The World Health Organisation warned on Tuesday that there could be a shortfall of up to two billion syringes in 2022, which threatens to hamper vaccine efforts globally if production does not improve.
The shortages are the result of COVID-19 vaccine campaigns, with billions of more syringes than normal being used worldwide, badly denting global supplies.
Lisa Hedman, the WHO’s senior advisor on access to medicines and health products, said as the supply of COVID-19 vaccine doses increases, the supply of syringes needs to keep pace.
“We are raising the real concern that we could have a shortage of immunisation syringes, which would, in turn, lead to serious problems, such as slowing down immunisation efforts,” she told reporters.
“Depending on how the vaccine uptake goes, it could be a deficit of anywhere from one billion to two billion.”
More than 7.25 billion COVID-19 vaccine doses have been administered globally, according to an AFP tally.
That’s nearly double the number of routine vaccinations given per year – and twice the number of syringes required.
Hedman said one serious result of a shortage could be delays in routine vaccinations, which could have a public health impact “for years to come” if a generation of youngsters misses out on normal childhood vaccinations.
Shortages could also lead to the unsafe practice of reusing syringes and needles.
Hedman said any constraint on syringe supply could only be worsened by export restrictions and transportation problems.
She urged countries to plan syringe needs well in advance to avoid hoarding and panic buying situations.
Hedman said, “efforts are being made to reduce that risk to zero in terms of the actual number that we could be short”.
A recent study conducted by scientists from the University of Cambridge has found that mothers who smoke during pregnancy could be harming their unborn daughters’ fertility in years to come.
Meanwhile, experts have warned women against the risks of smoking while pregnant, as it predisposes their offspring to the risk of heart defects and other health problems.
The study published in the FASEB science journal, is the first to suggest that girls born to women who smoked during pregnancy may struggle to have children of their own.
The researchers, who experimented with pregnant rats, due to the similar reproductive system they share with humans, found that oxygen deprivation also known as hypoxia, which happens to smokers lungs while smoking, resulted in female mouse pups born with fewer ovarian follicles.
The scientists opined that girls born to women who smoked during pregnancy will see a similar reduction in ovarian function, which they say could result in loss of fertility and earlier menopause.
To arrive at their findings, the team placed pregnant female rats in reduced levels of oxygen, 13 percent compared to the standard 21 percent found in the air, from day six to day 20 of their pregnancy.
Thereafter, the researchers examined the reproductive tract of female pups at the age of four months and found a 30 per cent decrease in the number of ovarian follicles.
According to Dr Catherine Aiken, from the department of Obstetrics and Gynaecology at the University of Cambridge : “It is as if low levels of oxygen caused the female’s ovarian tissue to age faster.
“Biologically, the tissue appears older and the female would run out of eggs in other words, become infertile at a younger age,” Aiken added.
Despite the research being carried out using rats, previous rat studies looking at oxygen deprivation during pregnancy in relation to other conditions such as heart disease have been shown to be relevant to humans, she added.
Aiken explained further by saying pregnancy conditions such as pre-eclampsia, which also result in lower oxygen levels during pregnancy, could have similar results.
“Now that we’ve seen a link between hypoxia and fertility problems in rats, we know what to look for in women,” she added. “If the same turns out to be true for them, then women at risk will be able to take action by having children earlier in life or looking to assisted reproduction, such as IVF.”
The World Health Organisation, says it has distributed assorted Infectious Prevention Control materials to 42 Primary Healthcare Centres in Adamawa State.
WHO’s Coordinator in Adamawa, Mr. Semeeh Omoleke, disclosed this at the distribution exercise, on Tuesday in Yola.
Omoleke, represented by Mr. Katuga Emmanuel, WHO’s National Immunisation Officer, said that the materials were meant to safeguard the health of the populace in communities across the state.
He commended the management of the healthcare centres for ensuring effective utilisation of the kits earlier provided to them and urged them to sustain the tempo.
“On a good note, we have distributed this material before, this is additional supply we are given to you, all to safeguard the health of our populace in your various communities.
“It is not only for COVID-19, we want to ensure that all our populace are prevented from all diseases.
“Cholera just affected us and it is still ongoing, so our health workers should use these materials to ensure they and their patients are protected,’’ he said.
In his remarks, Dr. Bashir Ahmed, Executive Chairman, Adamawa State Primary Healthcare Development Agency, commended the gesture and pledged to ensure judicious use of the donated items.
Ahmed, represented by Ibrahim Talba, Director, Essential Drug and Logistics in the agency, said the gesture would assist to stem the spread of cholera in the state.
He also lauded the UN health agency for its interventions in the health sector, adding that it impacted positively on enhancing quality healthcare service delivery in the state.
The News Agency of Nigeria reports that the materials included isolation gowns, boots, antiseptics, gloves, among others.
More than 250 million COVID-19 infections have been recorded worldwide since the start of the pandemic, according to an AFP count compiled from official reports at 2100 GMT on Monday.
Globally, more than five million deaths from COVID-19 have been recorded so far, but the vast majority of those infected have recovered. Some, however, have continued to experience symptoms weeks or even months later.
The figures are based on daily reports provided by health authorities in each country.
A significant proportion of the less severe or asymptomatic cases remain undetected despite increased screening in many countries since the start of the pandemic. In addition, testing policies differ from country to country.
Europe is the region with the highest number of infections, registering more than 76 million COVID-19 cases since the start of the outbreak in China in December 2019.
Asia is the second most affected with 56,201,653 cases, followed by the United States and Canada (48,290,522 infections) and Latin America and the Caribbean (46,107,131).
The number of new cases around the world has been slowly increasing over the past few weeks.
Nearly 449,000 new daily infections have been recorded on average over the past seven days, against just over 400,000 in mid-October.
Of the new infections recorded worldwide, more than 60 per cent are in Europe, which has seen an average of 279,000 cases a day over the past seven days.
A US woman and her husband are suing a fertility clinic they say implanted a stranger’s baby, lawyers said Monday.
When Daphna and Alexander Cardinale first saw their newborn, conceived through IVF, they noticed the baby girl had jet-black hair and a much darker complexion than anyone in their family.
A DNA test several months later revealed the girl born in September 2019 was not related to either of them, and they had been raising another couple’s child.
Lawyers in Los Angeles say two laboratories connected by one doctor switched the embryos of two entirely separate couples and implanted them in the wrong mothers.
The couples eventually met and worked through the courts to gain custody of their genetic children.
“The moment our… daughter was born should have been among the happiest of my life,” Alexander Cardinale said.
“But I immediately felt shaken and confused as to why I didn’t recognize her.
“When the truth came to light, it made exchanging the children all the more heartbreaking,” he said.
“Losing the birth child you know, for the genetic child that you don’t know yet… a truly impossible nightmare.”
The suit is seeking to recover emotional damages, compensatory and property damages and a wide range of costs, lawyers Peiffer Wolf Carr Kane & Conway said.
In IVF, the sperm and egg are combined and cultivated in a laboratory setting before the resulting embryo is implanted into the mother’s uterus.
The procedure is often used when a couple has trouble conceiving. It can also involve the donation of either eggs, sperm or both.
Non-meat eaters, especially vegans, have higher risks of either total or some site-specific fractures, particularly hip fractures, an Oxford study has found.
According to the researchers, this is the first prospective study of diet group with both total and multiple specific fracture sites in vegetarians and vegans, and the findings suggest that bone health in vegans requires further research.
The prospective EPIC-Oxford study, published in the journal BMC Medicine, states that, when compared with meat eaters and after adjustment for socio-economic factors, lifestyle confounders, and body mass index, the risks of hip fracture were higher in fish eaters, vegetarians, and vegans.
Scientists say fractures in adulthood and older ages are a common occurrence which pose a significant burden to health systems worldwide.
Previous epidemiological studies have shown that vegetarians had lower bone mineral density (BMD) than non-vegetarians, but the link between vegetarian diets with fracture risks are unclear.
Potential risk differences are plausible, however, owing to differences in several dietary factors, such as the substantially lower intakes of calcium in vegans, lower intakes of dietary protein in both vegetarians and vegans, and the lower body mass index (BMI) of non-meat eaters.
Prior studies had linked both calcium and protein intakes to bone health, but their relationships with fracture risks are nuanced.
For calcium, although previous meta-analyses have found that calcium supplements are effective in producing small increases in BMD, it is less clear whether this degree of improvement would be sufficient to reduce fracture risks.
However, a recent meta-analysis of randomised trials showed that combined vitamin D and calcium supplementation, but not vitamin D supplementation alone, was effective in fracture prevention, therefore supporting the importance of calcium.
For protein, while older studies suggested that high protein intake might lead to higher calcium excretion and therefore weaker bones, more recent evidence has suggested a positive association between protein and bone health, although this might not translate to differences in fracture risk.
This is the first comprehensive study and the largest study to date to look at the risks of both total fractures (fractures occurring anywhere in the body) and fractures at different sites in people of different habitual dietary habits,” said the study’s lead author, Tammy Tong, a nutritional epidemiologist at the Nuffield Department of Population Health at the University of Oxford.
“The study findings support a growing body of research on bone health with protein and calcium intake as well as BMI (body mass index),” said Lauri Wright, a registered dietitian nutritionist and chair of the department of nutrition and dietetics at the University of North Florida, who wasn’t involved in the study. “Protein and calcium are the two major components of bone,” Wright added.
Protein and calcium are better absorbed from animal foods,” said Katherine Tucker, a professor of nutritional epidemiology at the University of Massachusetts, Lowell, who wasn’t involved in the study.
“Some vegetarians say, ‘Well, if you look at the food tables, I have enough calcium.’ But calcium in whole grains is bound by phytates and in green leafy vegetables, it’s bound by oxalates,” Tucker added.
“Though meat-eaters typically consume higher amounts of protein, calcium and vitamin D and the nutrients are more bioavailable (able to be used by the body), a person may still be deficient if their food choices are poor,” Wright, who is also a spokesperson for the Academy of Nutrition and Dietetics, added.
L-R: Dr Maureen Nwafor, national vice chairman, CPAN; Dr Joseph Madu, national chairman, CPAN; Pharm. Ahmed I. Yakassai, former PSN President, Dr N.A.E Mohammed, registrar, PCN & SCPAN Award Recipient, Dr Moteehat O. Olu-Lawal, national secretary , CPAN; and Pharm. Lizzette Esinmoye, director of ceremony, at CPAN AGM.
In recognition of their immense contributions towards the advancement of Clinical Pharmacy Practice & Education in Nigeria, Clinical Pharmacists Association of Nigeria (CPAN) has conferred on the Immediate Past President of the Pharmaceutical Society of Nigeria (PSN), Pharm. (Mazi) Sam Ohuabunwa and Registrar, Pharmacists Council of Nigeria (PCN) Dr N.A. E Mohammed, an award of Grand Ambassador of CPAN (GCPAN) and Special Ambassador of CPAN (SCPAN), respectively.
The award presentation took place at the CPAN Special AGM/Get-together, at the just concluded 94TH Annual National Conference of the PSN, held in Port Harcourt, Rivers State.
CPAN also launched its maiden edition of the Nigeria Journal of Clinical Pharmacy and Therapeutics at the event.
In the same vein, the National Chairman, CPAN, Dr Joseph Madu, was also celebrated at the conference, as he emerged as the winner of Pfizer Excellence Award, established by the multinational pharmaceutical company, Pfizer.
An elated Madu, who was selected for the award based on his contributions in the field of Community Pharmacy, said he dedicated the award to God Almighty, all staff and management of CEDITH Pharmaceuticals Port Harcourt.
He expressed his profound appreciation to Pfizer for the rear privilege, to be selected as the winner of the excellence award, saying it serves as a great motivation for him to do more for the profession in the areas of clinical pharmacy and community pharmacy.
Madu reiterated the mission of CPAN, which is to foster excellence in clinical pharmacy practice, research and education in the country, with the ultimate goal of ensuring provision of outstanding patient care by practitioners.
“The association was formed in response to the need to drive clinical pharmacy practice forward in Nigeria. It aims to support and encourage excellence, partnership and leadership within clinical pharmacy practice in Nigeria. It also seeks to further the profession of Pharmacy, interests of clinical pharmacists in particular and public interest in general.
“The association provides opportunities for networking, collaboration, sharing best practices and inspiring innovation. CPAN will continue to be both supportive and stimulating, offering our members the opportunity to explore, learn, innovate and flourish” he disclosed.
Rev. Sam Tumba, the Parish Priest of Holy Rosary Catholic Church, Wuse, Zone 11, has urged church members not to doubt the veracity of COVID-19 vaccines.
He urged them to go ahead and take the jab.
Tumba gave the advice at the ordination of five deacons as Catholic priests which also marks the 40th ordination anniversary of the Archbishop of Abuja Diocese, Ignatius Kaigama, at the SS Peter Catholic Church, Nyanya, on Friday.
He said that the COVID-19 vaccines were meant to prevent virus and turn save lives.
“We have no reason to doubt the veracity of the production and administration of the vaccines.
COVID-19 Vaccines: Catholic Priest Urges Church Members Not to Doubt Their Veracity
“The Pope has taken the vaccine, so also the Archbishop and so church members should go ahead to take them.
“We should not allow ourselves to be misled by people propagating conspiracy theories about the vaccines,” he said.
Tumba, however, encouraged the newly ordained priests to remain focused and humble.
He noted that their ordination would greatly impact the church in the area of workforce.
He urged the ordained priests to be cautious and act Christ-like before the people of God.
Quoting the biblical book of Acts of the Apostle, Chapter 1, Verse 8, he said the ordination would prepare the priests for the universal mission of salvation.
According to him, the priesthood is a mysterious journey but only your faith will keep you going.
“Over the years, we have seen the growth of our diocese. In the past, we may be borrowing priests but today the archdiocese can boast of sending priests for missionary.
“With the ordination of the new five priests, this will bring the total number of priests in the Abuja diocese to over 100.
“We are happy that the archdiocese of Abuja has done well, we can equally send out priests to work in other dioceses in the world,” he said.
The priest added that the journey of the five into priesthood began about a decade ago, while urging them to devote their lives to taking care of the needy in the church.
He, therefore, called on policy makers, who are members of the church, to help the church take its rightful place in the country.
The News Agency of Nigeria (NAN) reports that the five newly ordained priests are Rev. Fr Humphrey Ayegba, Joseph Dankyang, Micheal Nzumeang, Peter Agbo and Emmanuel Okonkwo.
The highlight of the ordination witnessed the investiture of priesthood robes on the ordained priests and anointing of their hands.
Also, the Cardinal Archbishop Emeritus of Abuja, Archbishop John Onaiyekan, congratulated the priests for their journey into the priesthood.
Onaiyekan urged them to keep in mind the purpose of their ambitions to do the work and as well build the church of God.
One of the ordained priests, Rev. Fr Joseph Dankyang, said that his love for priesthood and their lifestyles spurred him into becoming a priest.
Dankyang said this led him into deriving joy in the vocation while thanking priests who came his way during the journey for inspirations which led him to becoming a priest.
Greenhope Healthcare Limited, a subsidiary of Pemason Pharmaceuticals Limited, recently launched Loadanew, described as a wholesome haematinic supplement formulated to advance the art of healthy living among the population. In this exclusive interview with MOSES DIKE, the Product Portfolio Manager of Pemason, Pharm. Charles Chinwuba explains the benefits of the product and how it will redefine the standards of health maintenance. Excerpts:
Pemason Nigeria Limited recently launched a new product called Loadanew. Kindly tell us about the product and why you think it is needed at this time in the Nigerian market?
As you rightly noted, the name of the new product is called Loadanew tonic. Loadanew is a complete and wholesome hematinic supplement from the stable of Greenhope Healthcare Ltd, which is a subsidiary of Pemason Pharmaceuticals limited. We believe that Loadanew is exactly what people have been waiting for because it is the complete formula with all the blood-forming factors and vitamins, alongside amino acids and other minerals.
The product is a pleasantly flavoured, protein-fortified, blood-forming-factor balanced, hematinic syrup, designed to help sick people quickly recover from their debilitating and destabilising health conditions that compromise the effective functioning of their body systems; while on the other hand, helping healthy people maintain the equilibrium of factors and nutrients necessary for optimal cell, organ and body function. These features are the things that make Loadanew very relevant for the maintenance of the health of our growing population in Nigeria
Anaemia is major challenge for pregnant women and patients living with sickle cell disease. What are some innovations of this product that will make it more beneficial to people in this category. Can it also be used as prophylaxis for anaemia prevention and other related disease conditions?
Yes, Anaemia is a major challenge for pregnant woman. In fact, the World Health Organisation (WHO) estimates that anaemia affects more than half (60 per cent) of pregnant women in developing countries, including Nigeria. About 7 per cent of them are further categorised as severely anaemic. The reason is understandable – pregnant women are considered two human beings in one. The nutritional habits of the average pregnant woman in developing countries are barely able to take care of the needs of one person, how much less when they are two.
In pregnancy, the metabolic, anabolic, catabolic, nutritional, haematologic requirements and activities usually need to increase or even double to take care of the extra being carried. This is why we have ensured that Loadanew is fortified with the extra nutritional ingredients they need to prevent shortfalls or to take care of it where it already exists.
The constituents and their doses are carefully selected and calculated to tune-up all the blood forming organs and activities in the body, as well as support optimal functioning of the system for a healthy life.
It is also effective as a preventive tonic, even before the anaemia manifests. Remember, prevention is always better and cheaper than cure.
Pemason is known for its strong brands in the ethical market. The launch of Loadanew appears to be a slight diversification into the OTC market. Is this part of the company’s strategic marketing plan?
Yes, as you rightly noted, Pemason is known for its strong ethical portfolio, especially in the cardiovascular and antibiotic categories. We have driven that ethical “train” for long, since inception. But recently, management thought about “softening” our portfolio a little bit, by launching into the OTC market, for purposes of diversification. It is purely strategic and we have a couple of products in that category under consideration. At the fullness of time, we will make them available.
Pricing and effective distribution are major challenges for new products in Nigeria.
What measures are you putting in place to ensure that this product is available and affordable to patients across Nigeria?
As for the pricing of Loadanew, we have carefully analysed the constituents and that is what the patients stand to gain – having obtained them as raw materials (API) from the purest of sources and compared their doses mg per mg with the available brands presently in the market – and can assure you that whatever penny a customer or patient spends on Loadanew is money well spent.
Loadanew offers the customer the best combination of nutrients and these include blood-forming factors, multivitamins, minerals, amino acids and immune enhancers at the highest concentration for the amount spent, vis-a-vis the amount required to deliver the needed effects in the body.
As for the distribution, we, trust and are relying on the effective network of Pemason Pharmaceuticals Limited, which has at least one medical/sales representative in all states of the federation.
The reps themselves are supported by our effective and capable distributors scattered all over different geo-political zones of the federation. We are confident that Nigerians will find this product available at affordable prices.
The Faculty of Pharmacy, Usmanu Danfodiyo University, Sokoto, has stated that its present priority is to embark on productive research and collaborations that will contribute to solving the various challenges plaguing the Nigerian health sector.
Dean of the faculty, Professor Musa Yerima, disclosed this in a recent interview with Pharmanews, stressing that the faculty is aware of the myriad of challenges facing the country’s health sector and thus making effort to produce students that will bring about the needed solutions.
Yerima noted that, although the faculty was established in 2008, the standard of training has been very high, in comparison with other schools of pharmacy in the country.
He said: “The faculty, with the support of the university management, is doing everything possible to comply with the Pharmacists Council of Nigeria (PCN) and the National University Commission’s benchmark minimum academic standards.
“Our focus at the faculty is mainly to be improving research and collaborations that will be productive in solving pressing challenges in the Nigerian pharmaceutical industry and the health sector. So, what we are focusing on is to keep producing quality pharmacists that will help in solving the health challenges in Nigeria and the world at large.
“Added to that is to further improve the standard and quality of pharmacy education both at the undergraduate and postgraduate levels.
“Our aspiration for our students is clearly defined – we want them to become the best pharmacists in the world in different areas of pharmacy practice: academia and research, industry, hospital and community practice.”
Also commenting on the nation’s overdependence on drug importation, Yerima disclosed that the faculty is equally striving towards new pharmaceutical product development, so as to bridge the gap.
According to him, “The faculty is doing a lot on drug development, especially from natural sources. The faculty is planning effective collaborations with relevant stakeholders, with the aim of providing necessary raw materials for local production of essential drugs.
“We have many grant-winning researches that focus on this area. Other aspects like pharmacotherapy, pharmaceutical analysis and dosage form development have also received much attention from many research teams in the faculty.
“The faculty has a world class, state-of-the-art Center for Advanced Medical Research and Training (CAMRET), where our researchers conduct most of their works. Discoveries are made regularly in the faculty.
“Various research groups in the faculty have grants and are working on cancer research, Biotechnology and antivenin activity of certain plants at the CAMRET. The faculty has 25 new offices and laboratories built and furnished by TETFund.”
The dean also told Pharmanews that the faculty is currently working on the establishment of a Drug Manufacturing Unit, with the support of the university management. He added that the faculty is already working hard on commencing its PharmD programme, stressing that the university senate had already passed the proposal.
Regarding the security of the faculty students, in view of the current challenges of insecurity in the northern part of the country, the dean stated that the school is a safe place to study and has never experienced any security threat to date.
“The faculty is located in the University Teaching Hospital, which is located in the heart of Sokoto town. Moreover, the university management has provided measures to improve the security on our campuses. The slogan of our university is “the most peaceful University in Nigeria”. This is no coincidence because we have never recorded any case of insecurity on any of our campuses,” Yerima said.
The dean further called on pharmacists in the country to rise up as a united entity to tackle the challenges bedeviling the nation’s health sector.
He said: “I want to appeal to pharmacists to use their training and competency in both the public and the private sector to help reduce the Nigerian health burden. We should all unite and see ourselves as one “Pharmily”. Also, our young colleagues should the avoid get-rich-quick syndrome which could lead to unethical practices.”
L-R Dr Osas Osunde, Xcene medical monitor, Adebukunola Telufusi, executive director, Xcene Research; Dr Nneka Onyejepu, NIMR research Fellow; Tobi Olaitan and Dr Faramola Ogunkoya, Xcene project manager, at the media briefing.
Towards bridging the gaps in clinical research and development as well as clinical trials in Nigeria, Xcene Research, a leading contract research organisation is billed to hold Impact Africa Summit (IAS) – the largest Pharmaceutical Research & Development and Clinical Trials Summit in Africa, from 1 to 3 December, 2021, at the Lagos Oriental, Nigeria.
The conference, with the theme: “Building sustainable capacity for clinical research through partnerships in Africa” will be organised in collaboration with key stakeholders from NAPA, NAFDAC, NHREC, NIPRD, NIMR and NMA.
Addressing journalists at a press conference to announce the summit, Executive Director, Xcene Research, Adebukunola Telufusi, expressed the vision of the organisation in changing the narrative in clinical trials in Nigeria and Sub-Saharan Africa, which was what birth the team in 2015, as they have tenaciously pursued the goal in establishing solid relationships with major players in the industry to buy into their objectives, which is coming into fruition with the summit.
She said: “Africa is emerging as an important destination for pharmaceutical R&D, clinical trials, and manufacturing. The Impact Africa Summit will elaborate on how building sustainable capacity for clinical research through partnership will help achieve our goal for healthier Africa. The 3- day event will have educative workshops, symposiums and lectures that will give valuable insights and rewarding experiences to patients and healthcare professionals. It will also be an avenue to reward and celebrate individuals who have made significant IMPACT in improving healthcare in Nigeria and Sub-Saharan Africa”.
Also speaking at the media briefing, Director General, Nigerian Institute of Medical Research (NIMR) Prof. Babatunde Salako, appreciated the timeliness of the IAS, which is coming up at the nick of time when the issues of clinical research and trials are on the front burner in the healthcare industry, with vaccine development as a major discussion across the globe.
The NIMR DG, who was represented by Dr Nneka Onyejepu, NIMR research Fellow, lamented dearth of clinical trials in the country, as Nigeria is missing on the landscape of clinical trials in Sub-Saharan Africa, which ought not be because the nation has the resources to conduct clinical research and development as well as trials on indigent population. He thus noted that the IAS will be a veritable platform to resolve bottlenecks around clinical trials in the country.
According to him: “The key thing is talking with key stakeholders on factors preventing trials in the country and finding solutions to the problems. Thus, this conference is timely; as it will be a place where all key stakeholders will sit down with the pharmaceutical companies to ask why they are not investing in Nigeria, why are they not bringing their products to test here, and then we can sit down to know what the issues are and how to resolve them. And then once the issues are identified, we will be closer to the goal than the point where will started from. NIMR will be fully part of it with all our resources”.
As a passionate researcher, Onyejepu revealed her vision to change the negative narrative on clinical trials in Nigeria to a positive one, saying “it’s my passion to see Nigeria on that landscape that when you talk about clinical research, when you talk about research and development in Africa, Nigeria will readily come to mind. We have the resources, we need to work with other stakeholders, private –public, to drive outcome of clinical research into polices that will be beneficial to all. If you’re talking about changing the healthcare landscape, it has to do with clinical research”.
Speaking on Xcene’s journey so far in the country in birthing an innovative healthcare system, the Xcene Project Manager, Dr Faramola Ogunkoya, said although they haven’t got to their destination, but the team has been able to secure the willingness of two international pharmaceutical companies to come and invest into clinical research, collaborate with others and build capacity. While admitting that it is a long term project, she said the summit will afford key stakeholders the opportunity to draw the blue print for the actualisation of the vision.
The Pharmaceutical Society of Nigeria (PSN) has elected Prof. Cyril Usifoh, as its new president.
Usifoh emerged winner at the elections held at the Civil Centre, Venue of the 94th Annual National Conference of the PSN in Port Harcourt, Rivers State.
Announcing the elections results early hours of Saturday, the outgoing PSN President, Pharm. (Mazi) Sam Ohuabunwa, said Usifoh edged out the three other contenders, polling a total of 855 votes, while Dr Lolu Ojo came second with 552 votes, Pharm. Tanko Ayuba polled 273 votes to secure third position, and Dr Daniel Orumwense polled 91 votes.
Also, Pharm. Binji Haliya Ibrahim won Deputy National President North with 799 votes, defeating Pharm. Tijani Yahaya Hamza who polled 567 votes and Pharm. Sani Bello who had 365 votes.
Similarly, Dr Egbuna Udeorah, has been elected Deputy National President South, after securing a total of 772 votes to defeat Pharm. Chima Ogbu, who had 670 votes and Agbojo Olukemi who scored 311 votes.
Pharm. Ikenna Chibueze Mbata, emerged the Assistant National Secretary, with 954 votes to beat his opponent Pharm. Ehitare Patrick Omoarebu with 790 votes.
For the unofficial members, Pharm. Obianuju Onwuatuegwu and Pharm. (Dr) Kingsley Amibor, cleared the two available slots with 974 votes and 658 votes respectively. While other aspirants of Pharm. Bolajoko Ajoke Aina and Pharm. Boyle Daba, had 598 votes and 355 votes respectively.
Amb. Cui Jianchun, Ambassador of the People’s Republic of China to Nigeria, says China is ready to support Nigeria in developing its Traditional-Medicine (Trado-Medicine) sector to boost the country’s economy.
Cui made this known on Thursday in Abuja during a seminar and lecture on “Developing Nigerian-Chinese Traditional Medicine”, oganised the Nigerian Youth Congress (NYC) in collaboration with the Chinese Cultural Centre.
According to Cui, Nigeria has a huge potential which when properly harnessed, with the support of the Chinese government will boost the country’s economy and promote good health and longevity of citizens.
He said that the Chinese government through its Embassy in Nigeria will train Nigerian youths of developing herbal medicine through technology driven process.
“I am thinking, how can we work together with Nigeria to solve this problem, China has done it and I do believe we can do it.
“I have discussed with the Youth Congress and we believe how can we give the youths the opportunity to take lead, to develop this country, so we think this project in medicine is good project.
“I fully promised the President how we can give the opportunity not only use the technology of medicine and try to build a project not only benefitting the people but also benefitting the economy.
“This I think how can we establish more pilot projects because traditional medicine really is important to the International Community and I do believe Nigeria we have our advantage, how can we catalyse, take advantage.
“And bring young people in this to take a lead and build a joint project and to make it successful and make it expand. How can we encourage young people to take the lead, to do something for this nation.
“This is not about lip service but leadership, to work together, mobilise the whole society to eradicate poverty, and I do believe we can get something and have Nigerians to work together.
“I hope this seminar is successful, it will be a good template to expand the food security,” Cui said.
Mr Mohammed Abdullahi, the Minister of State, Science and Technology, said that the goal of President Muhammadu Buhari is to eradicate poverty and herbal medicine has been revealed to yield about 50 billion dollars by 2030.
Abdullahi said it is important that youths are sensitised on the knowledge of herbal medicine from natural products for the treatment of diseases.
According to him, youths have a very important role in improving Nigeria’s economy if effectively sensitised on alternative medicine.
“The ministry through its agencies are ready to support the youths who have innovative ideas in herbal medicines as we have been partnering with appropriate institutions and some traditional medicine practitioners across Nigeria.
“To facilitate scientific evaluation, clinical trials and registration of herbal medicines found effective for the management of disease.
“The ministry is ready to collaborate with the Chinese government to improve herbal medicine in Nigeria.
“And subsequently send traditional medicine practitioners to China for adequate training and we will continue to collaborate,” Abdullahi said.
Mr Blessing Akinlosotu, the President, NYC, said the association, knowing the importance of traditional medicine to boost Nigeria’s economy, initiated the discussion with the Chinese Embassy.
He appreciated the Chinese Ambassador for his support, adding that Nigeria is also ready to learn from China’s success to develop its own traditional medicine sector.
“We initiated this with the Chinese Embassy and discussed on how we can collaborate to do so many things, and part of it is in the aspect of this traditional medicine.
“You will agree with me that China has the best of this traditional medicine and they are making a lot of huge amount from it.
“This tells you that if Nigeria and all the stakeholders come together to do same, because we have all the natural resources, the plants, the people, the practitioners.
“But the only thing we need to do is to encourage them, to see what we can do to bring governments to support them so that Nigeria can also generate a lot of economic gains from these traditional medicines,” Akinlosotu said. (NAN)
L-R: Pharm. David Onipe, marketing manager; Pharm. Helen Chime, pharmacist director/superintendent; Hon Chinaka Okani, MD/CEO and Pharm. Austin Akaeme, area sales manager (South-East) at the launch of the Alfa Vitamins by Mark Wellness in Port Harcourt, venue of the 94th PSN conference.
In furtherance of its commitment and dedication towards ensuring the availability and affordability of quality medicines to its teeming customers and Nigerians, Mark Pharmaceuticals Limited has launched a set of wellness products aimed at boosting the health of Nigerians.
The official unveiling of the products which took place during a presentation session at the 94th annual conference of the Pharmaceutical Society of Nigeria (PSN), had in attendance pharmacists and pharmaceutical scientists from Nigeria and beyond.
According to the Marketing Manager, Mark Pharmaceuticals Limited, Pharm. David Onipe, the over thirty range of products tagged “Alfa Vitamins by Mark Wellness” have been innovatively formulated through cutting-edge research to enhance the well-being of Nigerians, especially in an era of COVID and other infectious diseases. He added that the products are among the best of their kind in the market.
On his part, Managing Director of Mark Pharmaceuticals Limited, Mr Chinaka Okani, explained the rationale behind the launch of the products.
“As at last year, we got in contact with an American company, Alfa Vitamins and signed an MoU to market their products in Nigeria and in some other African countries. We have registered the products with NAFDAC and luckily the PSN conference presented itself as an opportunity for us to launch the products”, he stated.
On the potentials of the products in the very large and highly competitive Nigerian pharmaceutical market, he said: “These products will make a lot of mark in the Nigerian pharmaceutical market. This is going by the times we are in. Everyone needs wellness products to survive, bearing in mind the fact that we are in the era of COVID. You will also agree with me that, because of our busy schedules, most of us don’t have time to eat balanced diets and so such inadequacy is compensated with vitamins”.
Speaking on the affordability of the products, Mr Okani continued: “The products are available. And talking about affordability, you will better appreciate the importance of multivitamins and supplements when you realise their essential health benefits. It is better to be healthy than to complain about cost or patronise quacks”.
The Mark Pharma boss reiterated his company’s commitment towards making quality medicines available to Nigerians. “We are trying our best to remain very relevant in the Nigerian pharmaceutical landscape with our array of innovative products, specially formulated for the wellness of Nigerians and Africans, in general”.
Pharmacists in the country have been advised to get involved in politics to enhance their participation in the formulation of national policies bordering on Pharmacy profession and pharmaceutical related matters.
This was the trust of the Thursday Plenary Session at the ongoing 94th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) holding in Port Harcourt, Rivers State. The session titled: “Strengthen Pharmacy Practice through Political Action” chaired by the former PSN President and Chief Executive Officer, Barata Pharmaceutical Limited, Pharm. (Dr) U. N. O Uwaga.
While speaking on the topic, he noted that politics is relevant to every profession and more so to Pharmacy, so that the noble profession will not be sidelined.
One of the speakers at the session, a member of the Rivers State House of Assembly, Hon. Enemi Alabo George, expressed his worries when people who ought to be in leadership position abandon it in the hands of those that have no business in leadership.
The lawmaker, who noted that pharmacists are not utilising the powers they wield, averred that for pharmacists in the country to be able to influence policies that will favour the profession, they must be part of the politics.
“PSN should encourage members to join politics and as well constitute committee on politics. Pharmacists must be involved in the politics of the country to be able to influence policies. What pharmacists in Nigeria lack is action and interest. Don’t say politics is a dirty game, be part of it”, Hon George said.
Also speaking at the session, another speaker, a member of the National Assembly, Senator Sadiq Umar stated that Pharmacy practice in Nigeria can be strengthened through political action, but the political action requires all pharmacists to start joining politics individually and as a group by participating at all level and occupy political space.
In the same vein, the Special Assistant and Consultant to the Minister of Special Duties and Inter-government Affairs, Pharm. Alliyu Zakariyu, explained that, man by nature, is a political animal, but more importantly, pharmacists need to participate actively in the nation’s politics if the profession must overcome some of the challenges facing it and as well surmount problems in the pharmaceutical industry.
To strengthen Pharmacy practice through political action, Zakariya said pharmacists in the country must lobby the government so as to influence many policies and actions and this can best be achieved if pharmacists are active players in the nation’s politics.
He added that there is need for positive political practice to determine or affect policy and as well engage in political and social networking. He said pharmacists need to use diplomacy to be able to strengthen Pharmacy practice through political action.
The Managing Director of Miraflash Nigeria Limited, Pharm. Moses Oluwalade, is one of those who believe that the Pharmacy profession is primarily hinged on the accessibility and availability of quality medicines to the populace. In this exclusive interview with Pharmanews, at the 94th annual conference of the Pharmaceutical Society of Nigeria, Port Harcourt, 2021, he spoke with Patrick Iwelunmor, on issues relating to the vision of his company and what pharmacists must do to continue to add value to human existence. Excerpts
Sir, do you think this year’s PSN conference has lived up to its expectations?
Thank you very much. Within the limits of the constraints that we have in the Society, I believe that we actually tried. I was told that this venue is not the original venue but within a short time, the organisers were able to put things in order to avoid any further delays. I give it to them; they actually tried. However, there will always be room for improvement. My message to the PSN is that, there should always be opportunities for improvement. This edition has come. We should start thinking of the next edition and look into ways we can make it better than this one.
Going by the number of pharmaceutical companies exhibiting their products and services here in Port Harcourt, wouldn’t you say that the hue and cry about economic hardship in the country is contradictory; knowing that securing a stand here must have cost some good money?
The activities you see here are part of our passion to develop the Pharmacy profession. Beyond making money and selling our products, we have a primary assignment of ensuring the availability of quality medicines to the populace. As a pharmacist, I am not only concerned about the economic aspect of my business but more on the professional aspect. It is our priority as pharmacists to make quality medicines available to the society, irrespective of the economic outcome. Bad economy will come and go but we must continue to sustain the profession. Pharmacy is beyond business; it also has to do with the protection of lives.
What would you say is the value proposition of Miraflash?
We have been in the market, for over a decade and we have been making available high quality pharmaceutical products to the populace. However, it is not enough for your products to be of high quality. One important factor is the affordability of these products. It also must be available, and this is our vision: to make high quality pharmaceutical products available and affordable so that, in every home, no one will die because of unaffordability and unavailability. That’s our vision and what we have been doing and that’s what we will continue to do.
The PSN elections are at hand, what should be our expectations?
Our expectations should be that we are going to select a set of executive that will run the association and the gladiators have been campaigning. All the people that came out are men of substance. They are all qualified and the fact that you have this set of highly reputable people, shows that the association is moving forward. So, we should expect a very keen competition.
Your word of advice to the Pharmacy family in Nigeria.
I will advise that they should allow coherency and cooperation to reign amongst them. Let there be professionalism and we must make it our foremost vision. Every other thing should be secondary. We must begin to think of how to sanitise the drug distribution system in the country that is currently in a chaotic situation. If we can come together and do this, then there would be a reduction in the circulation of fake and adulterated drugs in our system.
As the National Health Insurance Scheme (NHIS) has been lagging behind in achieving Universal Health Coverage for the nation’s citizens, pharmacists have been charged to play active role to ensure that Nigerians have access to quality assured medicines, which will enhance the actualization of Universal Health Coverage.
While the NHIS has not been able to cover more than seven per cent of the Nigerian population since 2005 when it was launched, speakers at the day three of the ongoing PSN conference in Port Harcourt have said access to quality assured medicine will be a panacea to Universal Health Coverage in the country.
Speaking during the breakout session on Wednesday, on the topic “Access to Quality Assured Medicine As a panacea to Universal Health Coverage”, the lead speaker, who is the Executive Secretary/ Chief Executive Officer, NHIS, Prof. Mohammed Nasir Sambo, noted that Universal Health Coverage means nobody is left behind in accessing quality healthcare service, adding that health products is a global priority.
He however stated that the scheme has been faced with several challenges over the years which have hindered it from achieving its set target to the citizens.
According to the NHIS boss, the scheme has been confronted with many challenges, which has hindered it from making quality drugs available to all Nigerians and the challenges includes limited availability of drug products, limited acceptability of generics drugs as well as poor quality of drugs and products among others.
The NHIS boss however said the scheme is working hard to make things work out as expected to benefit all Nigerians, noting that the scheme is coming up with new initiative of drug branding, cost sharing and innovative financing.
Dr Chijioke Ofomata of Clinical Pharmacy, Nnamdi Azikwe University, who is also a speaker, noted that the goal of Universal Health Coverage is to ensure that everyone obtains the health service needed without suffering hardship when paying for them. He however lamented that substandard and falsified medicines have denied many Nigerians quality healthcare.
He therefore urged drug regulatory agencies, such as the National Agency for Food and Drug Administration and Control (NAFDAC) and the Pharmacists Council of Nigeria (PCN) to assume active roles in Universal Health Coverage and be up and doing.
On his part, Dr Ahmed Ndagi Mohammed of Dalas Medicare, who was also a speaker, opined that Universal Health Coverage cannot be achieved without the role of the pharmacists.
He therefore called on all pharmacists, pharmaceutical companies and regulators across the country to start playing active roles in the Universal Health Coverage by ensuring that Nigerians have access to quality medicines at all time.
The Lagos State Government, through its health regulatory agency, the Health Facility Monitoring and Accreditation Agency (HEFAMAA), has sealed Vedic Lifecare Hospital, Lekki, for allegedly “engaging unlicensed expatriates”.
Disclosing the development on Tuesday, the Executive Secretary of the Agency, Dr Abiola Idowu, explained that the hospital was shut down for engaging foreign medical personnel, who have not been certified to practice locally.
She said “The facility was shut down for engaging three foreign doctors and a nurse with unverified certificates and without licenses from any professional body”.
She however stated that the closure of the hospital does not affect the in-patients already admitted.
Idowu hinted that the Agency has got information that some facilities are engaging Foreign-Based Transient Medical Doctors (FBTMD) who come into the state, stay for a period of time to provide medical care to patients and perform medical procedures following which they return to their respective countries.
Reacting to the development, the Chairman, National Association of Nigerian Nurses and Midwives (NANNM) Lagos State branch, Comrade Olurotimi Awojide, condemned the hospital’s action, saying foreign-based nurses and doctors are expected to intimate themselves with local professional regulations before practicing in a new environment.
In a telephone chat with Pharmanewsonline, the NANNM Chairman, who said he was not very conversant with the hospital’s closure, however noted that an expatriate must comply with all regulatory agencies in the country of residence before practicing in the local community.
“A foreign nurse is expected to subject herself to the regulations of Nursing and Midwifery Council of Nigeria (NMCN) before practicing in the country. Same rule applies to the medical doctor, as he or she must report to the Medical and Dental Council of Nigeria (MDCN), thereafter consult with HEFAMAA for approval of practice, before embarking on any procedures. They must do the needful”.
In her response, the Chairman, HEFAMAA Governing Board, Dr Yemisi Solanke-Koya, noted that the practice raises consequential concerns regarding the regulatory oversight of healthcare in the state.
The concerns according to her focus on whether the facilities where the FBTMDs provide medical care are registered with and meet the standards required by HEFAMAA; whether the FBTMDs themselves possess the requisite credentials and experience required to practice the designated specialties they travel to the state for and whether the provisions made for the realm of continuity of care of the patients when the FBTMDs leave the State meet the standard of care.
The chairman warned that hospitals in Lagos should desist from using foreigners whose certificates and licenses have not been verified by the MDCN.
This is the season of planning for sales and marketing leaders, especially if your company runs a January-to-December calendar (as most do). If you’re in this category, you should be putting finishing touches to your 2022 sales plans. If you have not started, you are almost late. But the good news is that you might find this piece useful in crafting a robust and practical plan for the next year. If your financial year cycle gives you more time, then you are in luck.
What is planning?
Planning is inevitable for things we are well aware will happen in the future, as encapsulated in this saying, “By failing to plan, you are planning to fail”. This means that failure to plan is also a plan!
Another feature of planning is that it happens before the execution and result, as implied by, “It wasn’t raining when Noah built the ark”
What then is planning? I will describe it as deciding in advance what to do, how to do it, when to do it and who to do it. It involves anticipating the future and consciously choosing a future course of action. According to Haimann, “Planning is the function that determines in advance what should be done”.
While a goal is a desired future state that an organization attempts to realise, planning is the act of determining the organisation’s goals and the means for achieving them. A plan is a blueprint for action that specifies:
What is to be done – in numbers preferably and SMART
resources and resource allocations
actions necessary for attaining goals
schedules
Note that planning is:
goal-oriented
a continuous process
forward-looking
involves choice
directed towards efficiency
Benefits of planning
The question is, “why should we plan?” Here is a shortlist of benefits:
Focuses attention on objectives and result
Helps to determine new opportunities
Guides decision-making
Helps to anticipate and avoid future problems
Helps to develop effective courses of action (strategies and tactics)
Helps to comprehend and provide for the uncertainties and risks with various options.
Helps in setting standards
Challenges of planning
Obstacles on the way of proper planning include:
Lack of accurate information and data. Everyone who has had to plan in Nigeria will easily come against this obstacle. It is even more so in the pharma industry for lack of openness and data gathering cooperation.
It costs time and money to do a plan. Both are usually in short supply for sales managers.
Resistance to change by those who will run and implement it and those who will be affected by it, as it often requires doing things differently.
Lack of ability to plan. Leaders knows that effective planning requires knowledge and skills which are not automatically possessed by those whose responsibility it is to plan.
False sense of security, by figures generated and assumptions that have been made.
Environmental constraints, especially from issues outside the control of the planners (remember COVID-19) and policy somersault by governments!
What to plan
Planning is multi-dimensional, certainly with many of the items interlinked and interconnected. It is even important to point out that sales figures achieved are consequences of a selling process and execution of activities. Sales do not just happen. Such activities must be planned to ensure good result and desired outcomes. Below are my items to plan:
Sales: What products, SKUs, categories? What quantities do you want to sell? When? (specific period performance, say per quarter). Better to focus on volume than value/naira. Volume plans are more useful, realistic, accurate and easy to track.
Activities:
Number of calls per day (doctors, specialists, pharmacists, nurses, hospitals, institutions, wholesalers, key accounts, wholesalers, distributors, etc.)
Coverage. Would you need to cover new territories? If you want quantum growth, you need to plan to significantly increase your geographical, professional coverage, etc. What new market/target indication? What new products are you putting in the market? Would you need to reduce your product list to a manageable proportion?
Headcount: How many more (or less) reps would you need to achieve your plan/objectives? Do they need training? How many managers would you need to effectively supervise them?
Prospecting and lead generations. To grow (which is compulsory) you need to expand your customer base and get new customers. You need to plan how, how many and where these will come from
Other business-development activities and promotions
Budgeting
The chart below is an overview of budget and budgeting.
The first thing you need to be aware of is that sales budget drives many parts of the organisation: production/importation schedule, overheads, cash-flow, expenditures, including cap Ex, profitability, etc. It is a thus a serious business!
Sales budgeting therefore involves estimating future levels of revenue from sales, selling expenses, and profit contributions of the sales function. From the foregoing, there are three dimensions of sales budgeting:
Sales budget – projection of revenue computed from forecast unit sales and average prices.
Selling expense budget – amount that the department may spend to obtain the revenues projected in the sales budget.
Profit budget – merged sales budget and the selling expense budget to determine gross profit. This I have found, from experience, is usually ignored by most sales managers. Yet, how will the company survive and grow if it is ignored by chief revenue officer?
Sales forecasting
Sales forecasting is estimating a company’s sale for a specified future period. Sales forecasting provides the starting point for assumptions used in various planning activities. It is also used for short-term financial control systems. The financial budget is dependent upon the sales forecast for the projected revenue figures.
There are five levels of concern in sales forecasting: Market potential, sales potential, actual sales forecasts, sales quotas, and sales budgets. Let’s break them further down:
Market potential – This is the highest possible expected industry sales of a good or service in a specified market segment for a given time period. For instance, the market potential for the sales of computer in Lagos state might be two units annually. This is based on buyers’ ability and willingness to buy.
Sales potential – refers to an individual firm’s market share of the market potential, where market share is defined as the percentage of market controlled by a particular company or product. It is the maximum sales a firm can hope to obtain.
Sales forecasts – is the sales estimate the company actually expects to obtain, based on the market conditions, company resources, and the firm’s marketing plan. The sales forecast is less than the sales potential, since it is based on realistic set of circumstances.
Sales quota/target – is a sales goal assigned to a salesperson, region or team. It is usually derived from the sales forecasts. Sales goals and objectives sought by management.
Sales budgets – a management plan for the expenditures to accomplish sales goals. This is derived from sales target, but is like a more realistic target. Most Sales managers are assessed based on budget, while lower-level sales managers are assess based on target. The difference is usually between 10 and 20 per cent.
Sales budgeting process
Below is a summary of the process to develop a useful sales budget:
Situational analysis – sales managers have to look at the magnitude of past differences between budgeted and actual figures and the reasons for these differences.
Identification of problems and opportunities – the actual potential threats and challenges have to be assessed and addressed to determine the probabilities of occurrence and their impact.
Development of sales forecast – A manager is equipped to forecast sales, using one of the various methods. Projections are made about the anticipated levels of sales by territory, product or type of account. It is expressed both in units and dollars.
Formulation of sales objectives – once the forecast has been developed, the sales force has to be told what sales target to strive at and what objectives to pursue.
Determination of sales tasks – the sales manager and the sales force have to carry a broad array of sales activities, ranging from recruitment to evaluation, and from prospecting to after-sales service.
Specification of resource requirement – that is, the resources that will be required to implement the specified activities and achieve the objectives.
Completion of projections – here, all the input and requests from the various units of the sales function are assembled and tied into a comprehensive package.
Presentations and review –present and defend the sales budget proposal before the management.
Modification and revision – sales managers have to engage in a series of compromise sessions. Here, the sales targets and budgets might be adjusted by the higher management, reflecting both the needs of the corporation and the true potential of the marketplace.
Budget approval – final levels are eventually approved and authorised for both the sales and the selling expense budgets. Here, onwards budgets are reviewed periodically looking at the on-going market conditions and other external forces.
Finally, you must know that sales budget and sales target are not exactly the same, though sometimes used interchangeably. Needless to say that there is a very direct relationship between them and that sales target is necessarily higher than sales budget
Tunde Oyeniran, a Sales/Marketing Strategist, Selling/Sales Management Trainer and Personal Sales Coach is the Lead Consultant, Ekini White Tulip Consulting Limited, Lagos. We deliver Training, Recruitment and Field Force Management Solutions .Feedback. Channels 080-2960-6103 (SMS/WhatsApp) /ekiniwhitetuliptraining@gmail.com or check out https://fb.me/EkiniWhiteTulipConsulting
Five million people have died worldwide from COVID-19 since the disease first emerged in China nearly two years ago, according to a tally from official sources compiled by AFP.
Monday’s milestone, nearly four months after four million deaths were registered, came even as mortality rates slow thanks to a global vaccine rollout that has seen billions of people injected.
While the number of daily deaths worldwide fell below 8,000 for the first time in almost a year in early October, there remain blackspots globally.
“The total number of cases and deaths of COVID-19 is increasing for the first time in two months, due to the current increase in the epidemic in Europe,” World Health Organisation head Tedros Adhanom Ghebreyesus told a press conference on Thursday.
In the 52 countries and territories that form the WHO’s European region, the mounting death toll is mainly coming from the east.
Russia – a country with strong vaccine hesitancy – has seen infections and deaths reach new records, with average daily fatalities above 1,000 since October 20.
And according to the authorities themselves, this toll is largely underestimated.
The government’s daily toll shows a total of 239,693 deaths as of 1 November.
However, national statistics agency Rosstat, which has a broader definition of Covid deaths, said at the end of September that the death toll was nearly 450,000.
After Russia, Ukraine and Romania are the two countries in Europe with the highest daily death toll – averaging 546 and 442 deaths per day, respectively, over the past seven days.
Latin America and the Caribbean is the world’s deadliest region (1,521,193 deaths since the start of the pandemic).
But the number of daily deaths, currently around 840, has been declining since May.
In the United States, more than 1,400 deaths were recorded each day on average over the past seven days, 15 percent down on the previous week. With its total of 746,747 deaths, the country is bearing the brunt of the pandemic.
The WHO estimates that the pandemic’s real toll could be two to three times higher than official records, due to the excess mortality that is directly and indirectly linked to COVID-19.
The Economist magazine looked at excess mortality and concluded around 17 million have died from COVID.
“This figure seems more credible to me,” Pasteur Institute epidemiologist Professor Arnaud Fontanet told AFP.
Whatever the case, the death toll is lower than from other historical pandemics, such as Spanish flu that killed 50-100 million in 1918-1919.
Nonetheless, COVID-19 has “caused a lot of deaths in a short period”, said Jean-Claude Manuguerra, a virologist at the French institute.
“It could have been a lot more dramatic without all the measures taken, particularly restrictions on the movement of people and then the vaccinations,” according to Fontanet.
Two more bodies were pulled out early Wednesday from the debris of a collapsed Lagos high-rise building, bringing the death toll to 22 people, the emergency services said.
The 21-storey building was still under construction when it crumbled on Monday in the upscale Ikoyi neighbourhood of Nigeria’s commercial capital.
Rescuers said Wednesday they had recovered 22 dead bodies so far and rescued nine people who survived, but construction workers feared dozens of their colleagues were trapped inside.
“We recovered two male bodies early this morning, bringing the toll to 22,” Ibrahim Farinloye of the National Emergency Management Agency told AFP.
The number of survivors still stood at nine, he said, adding that search and rescue operations were still on.
The hope of finding more survivors appeared to dim as the rescue operation entered the third day on Wednesday.
“We won’t give up until we reach ground zero,” Farinloye said, adding that bigger equipment was brought in Tuesday evening for the operation.
He had earlier said rescue workers had been communicating with other survivors still trapped under the destroyed building.
Distraught relatives and friends of the victims have been besieging the scene since Monday, seeking information on their fate.
Two other smaller buildings in Lagos also collapsed on Tuesday following heavy rains in the densely populated city a day earlier, though no one was killed, he said.
Building collapses are tragically common in Lagos and across Africa’s most populous nation where substandard materials, negligence and a lack of enforcement of construction standards are major problems.
– ‘Like his own daughter’ –
Lagos state police said it is too early to determine why the Ikoyi building collapsed, but Lagos emergency management agency manager Femi Oke-Osanyintolu said infractions had been committed in its construction.
“We are going to get to the roots of the matter to prevent a recurrence,” he told AFP.
About 20 onlookers, including family embers and friends of the victims, were at the site on Wednesday morning.
A friend of a victim who did not want to be identified “because it won’t change anything”, said that “what they are doing is a retrieval operation, not a rescue operation”.
Damilola Otunla, 29, sat on the pavement across the street pursuing a three-day vigil for her brother Bob-Oseni Wale, 50, believed to have been inside the high-rise when it collapsed.
When she heard the news of the disaster on Monday, she immediately rushed to the scene from her home in neighbouring Ogun state.
Wearing the same grey hoodie, black shorts and flip flops since Monday, Damilola looked sad, her eyes empty, as she recalled how her much older brother acted like a father.
“He took me like his own daughter,” she added.
She was angry with the slow pace of the daily rescue efforts, which had not started as of 8:30 am Wednesday.
“It is like they have made their decision already,” she said.
Other family members were also at the scene.
Bob-Oseni lives in the US state of Maryland but had been home for the past few months and was visiting a friend working on the building site, his family said.
He was meant to fly back on Monday when the tragedy happened.
In one of Nigeria’s worst building disasters, more than 100 people, mostly South Africans, died when a church guesthouse crumbled in Lagos in 2014.
An inquiry found the building had been built illegally and had structural flaws.
Two years later, at least 60 people were killed when a roof fell in on a church in Uyo, the capital of Akwa Ibom state, in the east of the country.
Over the years, there has been a lot of curiosity as to whether chewing gum is good for the body or if we should stay away from it. This curiosity has led to studies to see what effects chewing gum have.
As early as 1939, Leta Hollingsworth, American psychologist, and educator did some detailed investigations and came up with connections between chewing gum and cognitive functions. From helping with hunger management, memory alertness, improved learning and anxiety, chewing gum does have health benefits on the body.
According to the story published on guardian.ng, here are some health benefits of chewing gum:
Prevents cavities and improves oral health: Sugar-free chewing gum is effective in preventing tooth decay with its effects being similar to mouth wash and toothpaste that contains fluoride; chewing on a sugarless gum after a meal can keep tooth decay and gingivitis at bay as well as promote tooth enamel. Chewing sugarless gum benefits your dental health since it doesn’t feed harmful bacteria in your mouth. Also, sugar-free chewing gum increases saliva production, which neutralizes acid in your mouth, prevents dry mouth and removes food particles from the teeth which could otherwise lead to tooth decay.
Eases acid reflux: Acid reflux is a situation where the stomach acid moves up to the esophagus (food pipe) and chest congestion while damaging it simultaneously which leads to the familiar burning sensation in the throat or chest. Chewing gum eases acid reflux by clearing the food pipe and neutralizing the acids to give some relief. If you suffer from chest burn or heartburn, chew gum after eating to lower the acid build up to ease chest burn and acid reflux symptoms. Chewing gum encourages saliva production and makes it more alkaline so that it can neutralize acid.
Aids digestion: Chewing gum before a meal helps improve digestion. This happens because the chewing action helps stimulate the mouth to produce saliva and the stomach to produce digestive acids thereby preparing the system for a meal; this in turn aids the effective digestion of food. Chewing gum after a meal also has its effects; it not only keeps the mouth healthy but also prevents indigestion by further stimulating the digestive process.
Fights nausea: Chewing gum also prevents nausea. People who are prone to motion sickness or morning sickness could get great relief from chewing herbal gum that contains ginger or mint so as to aid sliver production and digestion. The ginger and mint also work as well or better than some anti-nausea drugs. Chewing gum to prevent nausea is just as effective as prescription drugs for nausea only that its cheaper and has little to no side effects.
Manage appetite: When trying to lose weight, chewing gum is a good way to keep your cravings for sugary snacks at bay. When you get cravings for a snack, chewing gum is an effective way to reward yourself with adding the extra calories. This is also a way to curb the mindless nibbles of high-calorie snacks when relaxing or watching TV. Chewing gum helps control appetite, encourage dietary choices as well as born a few calories.
Eases ear blockade: Chewing gum is an effective method to drain water that gets clogged in the ears after a swim or a shower. Chewing gum helps clear the sinus cavities and pushes the liquid further out, clearing the ear. Chewing gum also naturally equalizes air pressure in the ear with outside pressure thereby relieving ear pressure, pain as well as ear blockage. So instead of pinching your nose and trying to blow your ears clear, it is preferable to chew gum because as the jaw opens and closes it equalizes internal and external pressure.
Prevents Dry Mouth and Freshens Breath: One of the reasons for mouth odor or bad breath is the lack of salivary flow and growth of excess bacteria that follows. Chewing mint flavored gum after meal masks strong odor from foods like onions and garlic as well as prevents bad breath. Chewing gum stimulates salivary glands and keeps the mouth fresh all day while killing the nasty bacteria.
The Association of Lady Pharmacists (ALPs) an interest group of the Pharmaceutical Society of Nigeria (PSN) has saddled the incoming president of the Society with the responsibility of making the impact of the profession felt by those in the corridors of power, saying this will pave way for the advancement of the profession in achieving its goals and objectives according to global standard of practice.
National Chairman of ALPs, Pharm. (Mrs) Victoria Ukwu, made this remarks, while fielding questions from Pharmanews, shortly after her presentation, during the vitual programme organised by the association to commemorate the International Day of the Girl Child, recently. She urged the would-be PSN president, to ensure by all means that pharmacists are not left at the back of the scene, but the profession must be brought to the fore to garner all the necessary recognitions from policy makers in order to be able to make informed decisions among other professionals in the country.
Aside bringing the Society closer to those in the helms of affairs in government, she also encouraged pharmacists to join politics, stating that it may be another avenue to resolve some of the recurrent issues the profession has been battling with over the years. “We need to be involved in governance. I’m using this opportunity to encourage our dear president to continue in his political ambition, we need it and we will continue to pray for him and support him”.
Faces of some of the participants at the virtual event.
Asked about her assessment of the Mazi Sam Ohuabunwa, led PSN administration, she rated him highly, especially with his innovation of regular Town Hall meetings, where he intimated pharmacists on progress made in the pursuit of various issues bothering the profession. His administration also secured the approval of the Consultancy Cadre for pharmacists, as well as his support for ALPs.
“The Mazi Sam Ohuabunwa led PSN administration has really tried in the area of information through the Town Hall Meetings, pharmacists were informed about issues concerning and affecting us and the profession. This has created the opportunity to dialogue and agree for the progress of the profession. His administration has also focused on the upliftment of pharmacists; an example is the approval of the Consultancy cadre for pharmacists. This is a great achievement in the history of the profession. The PSN president has supported ALPS and has given ALPS due recognition and we are very grateful for that. He was with us in Makurdi, Benue State for our 14th National Biennial Conference.
“The incoming PSN president should build on what the present administration has done and even more especially in the area of more visibility of Pharmacy in government through advocacy and encouraging/sponsoring pharmacists to join politics”, she stated.
Speaking on the theme of the 2021 International Day of the Girl Child “Digital Generation: Our Generation”, the keynote speaker Dr Tajudeen Abiola, consultant psychiatrist, Federal Neuro-Psychiatric Hospital, Kaduna, emphasized the importance of building the capacity of the girl child digitally, in order for her to be more productive professionally and economically.
He urged ALPians to always focus on the positive use of digital technology to girls in all their outings, while they should deliberately discourage the girls from engaging in social vices with digital devices, as it has the power to ruin their careers and totally terminate their lives, if they don’t thread with caution.
The Chairman of the occasion, who is also President, West African Postgraduate College of Pharmacists (WAPCP), Distinguished Prof. Ceciia Igwilo, pointed out the essence of the day, as it was established by the United Nations in 2012 for unearthing and addressing the fundamental challenges facing the girl child. She said it is: “A day to bring to light the struggles of a unique set, a day to amplify our voices against primitive statements that a particular gender is undeserving of certain rights and a day to discuss the benefits of investing on a girl child, recognising her hard work and aiding her to fulfill her potential.
“This day is observed to raise awareness on the implications of gender inequality and eventually create opportunities for every girl across the world. According to UNESCO, about 132 million girls are out of school, with about 15 million not likely to be in the four-walls of a classroom. And apart from access to education, the gender inequality is glaring in other facets of life including legal rights, gender violence, forced marriages and the list goes on…
“It is no news that investing on a girl child has proven to bring dividends to any society that committedly embraces the idea. For instance, educating a girl child can prevent early marriages, decline in child mortality, prevent disease, avert genital mutilation, enhance a stable community, nurture and empower women in the workforce. All of these as we know are critical to breaking the cycle of poverty and boosting economic growth of any nation”, she highlighted.
The Vice-Chancellor, Chrisland University, Abeokuta, Prof. Chinedum Babalola, in her own presentation titled: “Digitalisation: An enhancement to the asset the girl child is”, examined an array of girls and women, who have made names in the field of science and technology, saying digitalization has been a game changer in the education sector, as it has been effectively deployed as a prominent technique in the whole gamut of education. She stated how it has bridged the gap in physical distance as well as embedded more scientific means of impacting knowledge from tutors to students.
She mentioned different initiatives established as interventions against discrimination of girl-child such as the Annual International Girls in ICT Day, launched by the International Telecommunications Union (ITU);Digital Literacy for Women and Girls: Community Centres for Women’s Empowerment in ICT, and so on. These are meant to show the need to create more unfettered access to digital technology for the girl-child, towards changing the narratives in girl-child’s education.
Babalola therefore concluded thus: “Rather than making assumptions about what girls want and need from technology, we must work with them to create solutions to the issues that affect them by enabling them to learn digital skills. Technology can become a powerful tool for girls’ voices to become louder and even reach further”.
On her own part, Pharm. (Hajia) Zainab U. Shariff, director, Traditional, Complementary and Alternative Medicine, Federal Ministry of Health (FMoH), listed the major challenges facing the girl child in the society and proffered solutions to them, as she called for the abolishment of any cultural practice that oppresses the girl-child or prevent her from attaining her desired vision in life. Some of the problems of the girl-child she mentioned are: teenage pregnancy/obstetrics fistula, early marriage, domestic abuse, child sex traffic, child labour, rape, illiteracy, poverty among others.
In addressing these issues, she called for proper parenting of the girl child, educational empowerment, e skill acquisition, entrepreneurship, talent hunt in girls, implementation of Girl Child Right Act 2003 by all states of the federation, as these and others will brighten the future of the girl child.
Other participants at the event include: Chief (Mrs) Yetunde Moroundiya, former ALPs national chairman; Dr (Mrs) Modupe Ologunagba, ALPs national vice-chairman, South-West; Prof. (Mrs ) Olufunke A. Sodipo; Dr (Mrs) Afusat Adesina, ALPs chairman, Lagos State; Dr Arinola Jordan and others.
The Network of People Living with HIV/AIDS in Nigeria, Bauchi State chapter, on Tuesday sought the state government’s intervention in the treatment of members to curtail health complications among them.
The coordinator of the network, Mr. Abdullahi Ibrahim, told the News Agency of Nigeria in Bauchi that the N3,000 cost of the biannual haematology screening had scared members away from attending clinics.
He added that members could no longer access free supplements and antimalarial drugs in dedicated facilities since 2014.
“The cost of treatment is a burden to our members as only the antiretroviral drugs and sometimes Septrin, an antimalarial, are provided to patients free by development partners.
“Our members visit primary healthcare centres for drugs only since the haematology screening is conducted only at the Abubakar Tafawa Balewa University Teaching Hospital.
“The idea is that, if a house head has dependants that are all positive for the virus, he cannot afford to pay the bills.
“This will make the family members’ health deteriorate.
“People with HIV are to go through haematology screening after every six months and the charge at ATBUTH is N3,000.
“We are grateful to the present Chief Medical Director at ATBUTH who slashed the amount by 50 per cent to support us.
“If a client does not take the test, he or she will not know his or her condition,’’ Ibrahim said.
The coordinator acknowledged that the state government was committed to the fight against the spread of the disease.
Ibrahim also lamented the dearth of public enlightenment information about the virus in local communities and in media outlets.
He said that signposts and other visual materials were no longer available to create awareness about HIV.
The coordinator urged health workers to do more on enlightenment about mother-to-child transmission of the virus.
He said that health workers should be abreast with current information to ensure that babies were born free of the virus.
“Childbirth is another channel for transmitting the virus, the information is there in the dedicated facilities.
“We expect that quality and genuine information should come from health workers to stem new infections,’’ he said.
It was a beehive of activities on Tuesday at the Alfred Diete Spiff Civic Centre, in Port Harcourt, Rivers State, as thousands of pharmacists, not just in Nigeria but across African continent and America, gathered for the 94th Annual National Conference of the Pharmaceutical Society of Nigeria (PSN).
According to the PSN President, Pharm. (Mazi) Sam Ohuabunwa, as of Tuesday 2 November, 2021, day two of the conference, about 4,000 pharmacists were already in the Garden City for the event, a development he said would, no doubt, boost the economy of the state.
Speaking during his address, Ohuabunwa expressed optimism that pharmacists will recover what they must have lost in the past two conferences (Crocodile City 2019 – Kaduna and Omoluabi 2020 -Oshogbo), which were gravely affected by high spate of insecurity and COVID-19 pandemic respectively.
Pharm.(Sir) Ifeanyi Atueyi, Pharmanews publisher (middle) and wife, Lady Joan Atueyi, with a Pharm. Ben Tunde Enemmo at the conference.
Commenting on the theme of the 2021 conference, which is “COVID-19 Lessons: Broadening & Strengthening the Nigeria Pharmaceutical/Health Sector”, Ohuabunwa pointed out that Nigeria seems to have learnt some lessons from the pandemic as the Nigerian government and its various agencies have since been making some laudable moves.
“The Central Bank of Nigeria (CBN)’s 100 billion naira pharmaceutical / healthcare intervention fund, the dedicated fund for research, increased funding to NIPRD and the fact that the President of the Federal Republic of Nigeria, Muhammed Buhari, spent quality time in his 61st Independence broadcast, speaking about the government’s plan to support the industry, the first time in the history of Nigeria, are very strong pointers to the fact that we may have learnt a few he said.
The number pharmacist in Nigeria, whose tenure, as the president of PSN comes to an end on Friday 5 November, 2021, noted that his tenure was disrupted by unpleasant developments, especially the COVID-19 pandemic, notwithstanding, he did a lot to confront all the challenges that surfaced and recorded many accomplishments.
He said “Truly, we may not have accomplished all we hoped for, but we are definitely not where we were three years ago. We have advanced significantly in placing Pharmacy at a higher spectrum in the minds of Nigerians and in attracting respect and honour for our profession.
“We opened our Society for greater participation of members in governance, rejigged our constitution and did our best to build love and friendship in the profession, giving due honour and respect to all the organs of our Society, including the Board of Fellows (BoF), the College of past presidents (CPP), and Nigeria Academy of Pharmacy (NAPharm).
L-R: Former PSN Presidents, Alh.Yaro Budah; Ahmed I. Yakassai and incumbent President, Mazi Sam Ohaubunwa, at the opening ceremony of the 94th PSN conference.
“Many pharmacists broke career and professional ceilings and today, the difference between pharmacists, pharmacies and other pretenders are becoming more evident and easily differentiable as many pharmacists adopt the Pharmaceutical Care as minimum standard of care for all patients and clients. These have been achieved through the collective effort of members of the National Executive Committee (NEC), Council, the leadership and members of our statutory and ad-hoc committees. The energy, comradeship and teamwork was unprecedented”.
Ohuabunwa however urged the Nigerian government to provide a level playing ground for pharmacists and give the needed recognition and reward for the critical work they do. “The healthcare team must be treated as a team without undue bias or preference for any group. Nigeria government must recognise our pharmacies as bonafide component primary health care architecture and involve us in testing, vaccinations and other public health offerings as it is done in many other countries.”, Ohuabunwa said.
He also called for strong legislative support for the Pharmacists Council of Nigeria (PCN) and the National Agency for Food and Drug, Administrative and Control (NAFDAC), saying the intention of the government to have a sanitised and ordered pharmaceutical distribution system can never be achieved without adequate legislation.
In her keynote address, the Director General of NAFDAC, Prof. Mojisola Adeyeye, COVID-19 pandemic descended on Nigeria and the entire globe like a thief in the middle of the night and subsequently posed several challenges on Nigeria in particular, adding that the pandemic posed uncertainty on what will happen next.
The NAFDAC DG averred that the effect of the pandemic became enormous on Nigeria majorly because of drug insecurity, simply because Nigeria is importing the largest percentage of the drugs in the country, pointing that the nation’s drug importation, in actual fact, shouldn’t have been more than 30%, which she said she has been emphasizing since she became the DG of NAFDAC. She hoped that the nation will achieve the target in no distance time with determination.
Prof. Adeyeye however pointed out that Nigeria has learnt many lessons just as many other countries, stressing that some measures had been put in place before the pandemic broke, adding that the outbreak of the pandemic has also prompted the agency to make strategic moves that would help to move the pharmaceutical sector and the health sector, as a whole, to greater height.
Meanwhile, the Chairman of the occasion, Mr Odein Ajumogobia, has pointed out the need for Nigeria to be at the forefront of COVID-19 vaccine production, even as he charged pharmacists not to allow the advent of COVID-19 to make them lose focus.
In his remarks at the event, the former Minister of Foreign Affair said “Nigeria should be at the forefront of production of COVID-19 vaccine. The pandemic is yet to be overcame. In advanced countries Like UK and America, large percentage of people has been vaccinated by receiving the third dose of the vaccine, whereas, in Nigeria, less than 3% has received one dose, which is not good enough”.
The Benin Medical Care (BMC) says it has recorded no maternal mortality since its inception in 2019.
Dr Oluwagbemiga Durojaiye, Chief Executive Officer (CEO) of the hospital, disclosed this during the second year anniversary celebration of the hospital held in Benin on Monday.
Durojaiye said the hospital, established by the Lift Above Poverty Organisation (LAPO), was set up to uplift the health condition of the populace through provision of quality health care services.
According to him, the hospital has had 270 deliveries since inception through normal deliveries and cesarean sessions with no single record of maternal mortality.
He attributed the zero death of pregnant women during and after delivery to efficient antenatal services as well as prompt responses.
The CEO also said the hospital had more than 30,000 consultations, about 1,400 admissions and over 400 surgeries during the period under review.
“We have done outstanding knee replacement surgery and Transurethral Resection of the Prostate (TURP).
“The hospital is committed to the use of cutting edge technology and patient-centric approach to meet the health needs of the populace,” he said.
He said the hospital looked forward to dealing more on preventive medicine, minimal access surgeries and robotic medicine.
“We want to help people to become aware of their health through community outreaches, and the need for them to do regular check ups even when they don’t feel sick.
“We look forward to staff development; training and retraining, international collaborations, making functional our dialysis centre and partnership with LAPO C4 programme,” he said.
The highlight of the event was the inauguration of the VIP clinic in the hospital to provide executive care in a cosy environment. (NAN)
The best way to use this technique effectively is by getting a baseline of the suspect. While newborn babies only blink one to two times a minute, the average blink rate for an adult is four to 14. Any deviation from these could be because of fatigue, disease, medication that causes dryness in the eyes, or anxiety. The blink is a way the eye gets lubrication (aqueous humour).
An increase in the blink rate is a sign of nervousness, which may or may not be as a result of some kind of guilt. A decrease is a sign of cognitive load. Similarly, eye contact decrease or increase means nothing without reference to baseline. It is a common myth that whoever is not able to look at you in the face and respond to a probing question is a liar. Unless you make reference to the baseline of the suspect, you cannot categorically conclude that he or she is guilty.
Crime downplay
“Did you rape Victoria Jones two nights ago?” This was the question directed at a suspect and his response was “I did not take advantage of her.” To a layperson or someone without any skill on how to catch a liar, it is easy to gloss over such a statement but several red flags can be seen from that statement.
Anytime a crime suspect tries to give his or her own version, as it were, of a crime in question, using a tone or words that attempt to reduce the gravity, magnitude or the seriousness of the crime being spoken about, then such a gesture may be a deceptive one. Some other examples you can find that may warrant suspicions include the following:
“Did you hit your brother with a cutlass?” “I didn’t hurt him.”
“Did you gossip about me?” “I didn’t say anything bad about you.”
Self castigation
Wife: “Honey, you have forgotten that today is my birthday”.
Husband: “Of course I know. I would be the biggest fool with an incomplete brain as a husband to forget the birthday of a woman so wonderful like you.” Oops! Why such a rain of abusive words at yourself just to prove something? This response appears sincere but the fact is, the words with which the husband describes his ineptitude in this scenario are unnecessarily weighty. It is a red flag of a guilty husband in this context, to say the least.
The qualifying statements used in appreciation of his wife after having abused himself are only compensatory statements to cover up a defect in the relationship with his partner.
Closed gestures
In other to apply this technique adequately, you need to pay keen attention to the point at which the suspect deviates from the baseline to utilise any of the closed gestures typical of someone hiding something. That is the real value of this technique. It is a strong nonverbal cue leading to unfolding the hidden secret.
The two common types engaged in are the arm-fold gesture and the hands-in-pockets gesture, as seen in the pictures below.
It is important to note that the use of these gestures do not suggest that a lie is being told, not necessarily. However, it does show some kind of discomfort internally which could be driven by guilt of telling lies. Again, this is reliable only when the baseline considerations have been noted.
Concealment of the hands is seen as a deceptive gesture at the point where there is a deviation from the baseline (hot spot). It means the suspect is holding a piece of information back. However, even though hands restriction can signal deception, do not immediately conclude without a baseline to serve as a benchmark.
Unlike the closed gesture, open arm gestures most times show that the individual is truthful. That is because the nerve connection between the brain and other parts of the body used for expression cannot be compared with that of the hands/arms. This is why the gestures made with the arms cannot be overlooked as they serve as a valuable resource material in getting to know what is on the inside.
Don’t miss the next edition.
Culled from the book “How to catch a liar without polygraph”
Instagram (@dipomacjob) (07062456737 Text message)